
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5309168AEE2D630509160044C86686.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358767/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Pharmacoepidemiology and Drug Safety">
<meta name="citation_title" content="Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study">
<meta name="citation_author" content="Y Shi">
<meta name="citation_author_institution" content="Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA">
<meta name="citation_author" content="A Sun">
<meta name="citation_author_institution" content="Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA">
<meta name="citation_author" content="C W Chiang">
<meta name="citation_author_institution" content="Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA">
<meta name="citation_author" content="Y Yang">
<meta name="citation_author_institution" content="Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA">
<meta name="citation_author" content="K M Hunold">
<meta name="citation_author_institution" content="Department of Emergency Medicine, The Ohio State University, Columbus, Ohio, USA">
<meta name="citation_author" content="J Xu">
<meta name="citation_author_institution" content="Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA">
<meta name="citation_author" content="M Russo">
<meta name="citation_author_institution" content="Department of Statistics, The Ohio State University, Columbus, Ohio, USA">
<meta name="citation_author" content="J Caterino">
<meta name="citation_author_institution" content="Department of Emergency Medicine, The Ohio State University, Columbus, Ohio, USA">
<meta name="citation_author_institution" content="Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA">
<meta name="citation_author" content="M T Eadon">
<meta name="citation_author_institution" content="Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA">
<meta name="citation_author" content="L Li">
<meta name="citation_author_institution" content="Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA">
<meta name="citation_author" content="J Su">
<meta name="citation_author_institution" content="Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA">
<meta name="citation_author" content="M Donneyong">
<meta name="citation_author_institution" content="College of Pharmacy, The Ohio State University, Columbus, Ohio, USA">
<meta name="citation_author" content="P Zhang">
<meta name="citation_author_institution" content="Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA">
<meta name="citation_publication_date" content="2025 Aug 17">
<meta name="citation_volume" content="34">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e70199">
<meta name="citation_doi" content="10.1002/pds.70199">
<meta name="citation_pmid" content="40820442">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358767/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358767/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358767/pdf/PDS-34-e70199.pdf">
<meta name="description" content="Use of three‐drug combinations is increasingly prevalent and associated with an increased risk of adverse drug events (ADEs). While real‐world data‐based pharmacovigilance and pharmacoepidemiology studies have derived knowledge on potential adverse ...">
<meta name="og:title" content="Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Use of three‐drug combinations is increasingly prevalent and associated with an increased risk of adverse drug events (ADEs). While real‐world data‐based pharmacovigilance and pharmacoepidemiology studies have derived knowledge on potential adverse ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358767/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12358767">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/pds.70199"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/PDS-34-e70199.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12358767%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12358767/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12358767/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358767/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1002/pds.70199" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Pharmacoepidemiol Drug Saf</button></div>. 2025 Aug 17;34(9):e70199. doi: <a href="https://doi.org/10.1002/pds.70199" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/pds.70199</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Pharmacoepidemiol%20Drug%20Saf%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pharmacoepidemiol%20Drug%20Saf%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Pharmacoepidemiol%20Drug%20Saf%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Pharmacoepidemiol%20Drug%20Saf%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Y Shi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Y Shi</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shi%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Y Shi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">A Sun</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">A Sun</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sun%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">A Sun</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chiang%20CW%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">C W Chiang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">C W Chiang</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chiang%20CW%22%5BAuthor%5D" class="usa-link"><span class="name western">C W Chiang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Y Yang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Y Yang</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Y Yang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hunold%20KM%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">K M Hunold</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">K M Hunold</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Emergency Medicine, The Ohio State University, Columbus, Ohio, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hunold%20KM%22%5BAuthor%5D" class="usa-link"><span class="name western">K M Hunold</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">J Xu</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">J Xu</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">J Xu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Russo%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">M Russo</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">M Russo</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Statistics, The Ohio State University, Columbus, Ohio, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Russo%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">M Russo</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caterino%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">J Caterino</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">J Caterino</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Emergency Medicine, The Ohio State University, Columbus, Ohio, USA</div>
<div class="p">
<sup>
<sup>5</sup>
</sup>Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Caterino%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">J Caterino</span></a>
</div>
</div>
<sup>3,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eadon%20MT%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">M T Eadon</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">M T Eadon</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eadon%20MT%22%5BAuthor%5D" class="usa-link"><span class="name western">M T Eadon</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">L Li</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">L Li</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">L Li</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Su%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">J Su</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">J Su</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Su%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">J Su</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Donneyong%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">M Donneyong</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">M Donneyong</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>College of Pharmacy, The Ohio State University, Columbus, Ohio, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Donneyong%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">M Donneyong</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">P Zhang</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">P Zhang</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">P Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="pds70199-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Biostatistics and Health Data Science, Indiana University, Indianapolis, Indiana, USA</div>
<div id="pds70199-aff-0002">
<sup>
<sup>2</sup>
</sup>Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA</div>
<div id="pds70199-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Emergency Medicine, The Ohio State University, Columbus, Ohio, USA</div>
<div id="pds70199-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Statistics, The Ohio State University, Columbus, Ohio, USA</div>
<div id="pds70199-aff-0005">
<sup>
<sup>5</sup>
</sup>Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA</div>
<div id="pds70199-aff-0006">
<sup>
<sup>6</sup>
</sup>Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA</div>
<div id="pds70199-aff-0007">
<sup>
<sup>7</sup>
</sup>College of Pharmacy, The Ohio State University, Columbus, Ohio, USA</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
P. Zhang (<span>zhangpe@iu.edu</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Aug 3; Received 2025 Apr 22; Accepted 2025 Aug 4; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Pharmacoepidemiology and Drug Safety</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12358767  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40820442/" class="usa-link">40820442</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="pds70199-sec-0001"><h3 class="pmc_sec_title">Introduction</h3>
<p>Use of three‐drug combinations is increasingly prevalent and associated with an increased risk of adverse drug events (ADEs). While real‐world data‐based pharmacovigilance and pharmacoepidemiology studies have derived knowledge on potential adverse three‐drug combinations, the relationship between doses of each drug in three‐drug combination exposure and the risk of ADEs remains unclear.</p></section><section id="pds70199-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>We derived matched case–control datasets from US nationwide health insurance claims data for potential ADEs including acute kidney injury, acute myocardial infarction, gastrointestinal bleeding, hypoglycemia, and opioid‐related ADE. We used the conditional logistic regression model to investigate the relationship between the dose of three‐drug combination exposure and the risk of ADE. We used Benjamini and Hochberg's procedure to control the false discovery rate (FDR). We explored the relationship between the reduction of drug dose and the risk of ADE.</p></section><section id="pds70199-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>We identified over 500 potential adverse three‐drug combinations from approximately two million case–control pairs (all odds ratios ≥ 1.3 and FDR &lt; 0.05). For the signals, compared with a high‐dose level of all three drugs, 74% of three‐drug combinations had a lower risk by decreasing the dose of one drug without any drug discontinuation (<em>p</em> value &lt; 0.05).</p></section><section id="pds70199-sec-0004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Certain three‐drug combinations are associated with an increased risk of ADE. Dose of exposure might be used to evaluate the risk of ADE for a majority of adverse three‐drug combinations.</p></section><section id="pds70199-sec-0005"><h3 class="pmc_sec_title">Plain Language Summary</h3>
<p>Use of three‐drug combinations is increasingly prevalent and associated with an increased risk of adverse drug events (ADEs). We identified potential adverse three‐drug combinations from real‐world data, and revealed the corresponding relationships between doses and risks of ADEs. We find doses might be used to evaluate the risk of ADE for many adverse three‐drug combinations. Additionally, we find risk of many adverse three‐drug combinations might be decreased by reducing the dose of one drug without any drug discontinuation.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> adverse drug events, dose, drug combination, pharmacoepidemiology, toxicity</p></section></section><hr class="headless">
<section class="bt xbox font-sm" id="pds70199-blkfxd-0001"><h2 class="obj_head">Summary.</h2>
<ul id="pds70199-list-0001" class="list" style="list-style-type:disc">
<li id="pds70199-li-0001"><p>Certain three‐drug combinations are associated with an increased risk of adverse drug events (ADEs).</p></li>
<li id="pds70199-li-0002"><p>Dose might be used to evaluate the risk of many adverse three‐drug combinations.</p></li>
<li id="pds70199-li-0003"><p>The risk of an adverse three‐drug combination might be decreased by reducing the dose of one drug without any drug discontinuation.</p></li>
<li id="pds70199-li-0004"><p>Combination of opioid, other central nervous system drug, and antihypertensive drug might increase the risk of opioid‐related ADE.</p></li>
<li id="pds70199-li-0005"><p>Combination of kidney‐eliminating drug and other nephrotoxic drugs might increase the risk of acute kidney injury.</p></li>
</ul></section><section id="pds70199-sec-0009"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>The concurrent use of three or more drugs (i.e., multi‐drug combinations) has become increasingly prevalent due to the growing demand for the management and/or prevention of multiple conditions. A recent US nationwide survey reported that 21% of the adult population and 66% of the older adult population are currently taking three or more medications [<a href="#pds70199-bib-0001" class="usa-link" aria-describedby="pds70199-bib-0001">1</a>]. As many chronic diseases require indefinite pharmacological management [<a href="#pds70199-bib-0002" class="usa-link" aria-describedby="pds70199-bib-0002">2</a>], the use of multi‐drug combinations is expected to increase further in the near future with extended longevity [<a href="#pds70199-bib-0003" class="usa-link" aria-describedby="pds70199-bib-0003">3</a>].</p>
<p>Exposure to multi‐drug combinations is associated with an increased risk of adverse drug events (ADE) [<a href="#pds70199-bib-0004" class="usa-link" aria-describedby="pds70199-bib-0004">4</a>, <a href="#pds70199-bib-0005" class="usa-link" aria-describedby="pds70199-bib-0005">5</a>, <a href="#pds70199-bib-0006" class="usa-link" aria-describedby="pds70199-bib-0006">6</a>, <a href="#pds70199-bib-0007" class="usa-link" aria-describedby="pds70199-bib-0007">7</a>]. However, individuals with exposure to multi‐drug combinations are often underrepresented in clinical trials due to restrictive inclusion and exclusion criteria, limiting direct assessments of the relationship between multi‐drug combinations and the risk of ADE [<a href="#pds70199-bib-0008" class="usa-link" aria-describedby="pds70199-bib-0008">8</a>, <a href="#pds70199-bib-0009" class="usa-link" aria-describedby="pds70199-bib-0009">9</a>, <a href="#pds70199-bib-0010" class="usa-link" aria-describedby="pds70199-bib-0010">10</a>, <a href="#pds70199-bib-0011" class="usa-link" aria-describedby="pds70199-bib-0011">11</a>]. Alternatively, large‐scale real‐world data (RWD; e.g., nationwide health insurance claims databases) include ample individuals with multi‐drug combination exposure [<a href="#pds70199-bib-0012" class="usa-link" aria-describedby="pds70199-bib-0012">12</a>]. RWD‐based pharmacovigilance studies have identified potential adverse three‐drug combinations related to bleeding [<a href="#pds70199-bib-0013" class="usa-link" aria-describedby="pds70199-bib-0013">13</a>, <a href="#pds70199-bib-0014" class="usa-link" aria-describedby="pds70199-bib-0014">14</a>, <a href="#pds70199-bib-0015" class="usa-link" aria-describedby="pds70199-bib-0015">15</a>], hypoglycemia [<a href="#pds70199-bib-0014" class="usa-link" aria-describedby="pds70199-bib-0014">14</a>], myopathy [<a href="#pds70199-bib-0016" class="usa-link" aria-describedby="pds70199-bib-0016">16</a>, <a href="#pds70199-bib-0017" class="usa-link" aria-describedby="pds70199-bib-0017">17</a>, <a href="#pds70199-bib-0018" class="usa-link" aria-describedby="pds70199-bib-0018">18</a>, <a href="#pds70199-bib-0019" class="usa-link" aria-describedby="pds70199-bib-0019">19</a>], opioid‐induced ADE [<a href="#pds70199-bib-0014" class="usa-link" aria-describedby="pds70199-bib-0014">14</a>, <a href="#pds70199-bib-0020" class="usa-link" aria-describedby="pds70199-bib-0020">20</a>], and unintentional traumatic injury [<a href="#pds70199-bib-0021" class="usa-link" aria-describedby="pds70199-bib-0021">21</a>, <a href="#pds70199-bib-0022" class="usa-link" aria-describedby="pds70199-bib-0022">22</a>, <a href="#pds70199-bib-0023" class="usa-link" aria-describedby="pds70199-bib-0023">23</a>]. As these studies are based on an exposed versus non‐exposed setting, they also reveal the comparative risk between potential adverse three‐drug combinations and the corresponding two‐drug sub‐combinations (e.g., A + B + C vs. A + B/A + C/B + C), which offers new opportunities to prevent and manage ADE by reducing drug exposure. Additionally, Shi et al. [<a href="#pds70199-bib-0014" class="usa-link" aria-describedby="pds70199-bib-0014">14</a>] conducted therapeutic class‐based data mining to identify alternative low‐risk multi‐drug combinations that share similar therapeutic classes with the corresponding high‐risk combinations. These alternative low‐risk multi‐drug combinations could mitigate the ADE burden without a significant compromise on the existing treatment regimen.</p>
<p>While these studies provide valuable knowledge on potential adverse three‐drug combinations, the relationship between the dose of drug exposure and the risk of ADE remains largely unexplored. As drug dose is a significant risk factor of ADE [<a href="#pds70199-bib-0024" class="usa-link" aria-describedby="pds70199-bib-0024">24</a>, <a href="#pds70199-bib-0025" class="usa-link" aria-describedby="pds70199-bib-0025">25</a>, <a href="#pds70199-bib-0026" class="usa-link" aria-describedby="pds70199-bib-0026">26</a>], we leverage US nationwide health insurance claims data to identify potential adverse three‐drug combinations and to explore the relationship between reductions in drug doses, drug exposure, and the risk of ADE. Specifically, we focus on five types of ADEs (acute kidney injury [AKI], acute myocardial infarction [AMI], gastrointestinal [GI] bleeding, opioid‐related ADE, and hypoglycemia), as these ADEs are common and potentially serious [<a href="#pds70199-bib-0027" class="usa-link" aria-describedby="pds70199-bib-0027">27</a>, <a href="#pds70199-bib-0028" class="usa-link" aria-describedby="pds70199-bib-0028">28</a>, <a href="#pds70199-bib-0029" class="usa-link" aria-describedby="pds70199-bib-0029">29</a>, <a href="#pds70199-bib-0030" class="usa-link" aria-describedby="pds70199-bib-0030">30</a>], as well as likely caused by drug interaction and/or closely related to dose [<a href="#pds70199-bib-0031" class="usa-link" aria-describedby="pds70199-bib-0031">31</a>, <a href="#pds70199-bib-0032" class="usa-link" aria-describedby="pds70199-bib-0032">32</a>, <a href="#pds70199-bib-0033" class="usa-link" aria-describedby="pds70199-bib-0033">33</a>, <a href="#pds70199-bib-0034" class="usa-link" aria-describedby="pds70199-bib-0034">34</a>, <a href="#pds70199-bib-0035" class="usa-link" aria-describedby="pds70199-bib-0035">35</a>].</p></section><section id="pds70199-sec-0010"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<section id="pds70199-sec-0011"><h3 class="pmc_sec_title">2.1. Data Source and Preprocessing</h3>
<p>We used Optum's de‐identified Clinformatics Data Mart Database. The data were derived from US individuals enrolled in commercial health insurance and/or Medicare Advantage plans. The dataset included de‐identified information on enrollment, health encounter, diagnosis, and pharmacy claim. The Indiana University Institutional Review Boards (IRBs) designated this study as exempt.</p>
<p>Figure <a href="#pds70199-fig-0001" class="usa-link">1</a> illustrated the study design [<a href="#pds70199-bib-0036" class="usa-link" aria-describedby="pds70199-bib-0036">36</a>]. We included emergency department (ED) visits from 2008 to 2021 that had &gt; 365 days of enrollment and no ED visit within 180 days prior to the corresponding ED visit dates, regardless of whether the corresponding patients were discharged or hospitalized after ED visits. We used specific diagnosis codes to define five potential adverse drug event (ADE) outcomes including acute kidney injury (AKI) [<a href="#pds70199-bib-0037" class="usa-link" aria-describedby="pds70199-bib-0037">37</a>], acute myocardial infarction (AMI) [<a href="#pds70199-bib-0038" class="usa-link" aria-describedby="pds70199-bib-0038">38</a>], gastrointestinal (GI) bleeding [<a href="#pds70199-bib-0039" class="usa-link" aria-describedby="pds70199-bib-0039">39</a>], opioid‐related ADE [<a href="#pds70199-bib-0040" class="usa-link" aria-describedby="pds70199-bib-0040">40</a>], and hypoglycemia [<a href="#pds70199-bib-0041" class="usa-link" aria-describedby="pds70199-bib-0041">41</a>]. Additionally, we used R package comorbidity [<a href="#pds70199-bib-0042" class="usa-link" aria-describedby="pds70199-bib-0042">42</a>] to define risk factors for the potential ADEs. Specifically, the risk factors were (A) chronic pulmonary disease, diabetes, heart disease, hypertension, liver disease, peripheral vascular disease, and renal disease for AKI [<a href="#pds70199-bib-0043" class="usa-link" aria-describedby="pds70199-bib-0043">43</a>, <a href="#pds70199-bib-0044" class="usa-link" aria-describedby="pds70199-bib-0044">44</a>]; (B) depression, diabetes, heart disease, hypertension, and obesity for AMI [<a href="#pds70199-bib-0045" class="usa-link" aria-describedby="pds70199-bib-0045">45</a>]; (C) alcohol use disorder, anemia, cancer, coagulopathy, liver disease, and peptic ulcer disease for GI bleeding [<a href="#pds70199-bib-0046" class="usa-link" aria-describedby="pds70199-bib-0046">46</a>, <a href="#pds70199-bib-0047" class="usa-link" aria-describedby="pds70199-bib-0047">47</a>, <a href="#pds70199-bib-0048" class="usa-link" aria-describedby="pds70199-bib-0048">48</a>, <a href="#pds70199-bib-0049" class="usa-link" aria-describedby="pds70199-bib-0049">49</a>]; (D) heart disease, cerebrovascular disease, chronic pulmonary disease, rheumatoid disease, renal disease, cancer, drug abuse, depression, and psychoses for opioid‐related ADE [<a href="#pds70199-bib-0050" class="usa-link" aria-describedby="pds70199-bib-0050">50</a>], and (E) hypertension, diabetes, obesity, and heart disease for hypoglycemia [<a href="#pds70199-bib-0051" class="usa-link" aria-describedby="pds70199-bib-0051">51</a>]. Please see <a href="#pds70199-supitem-0001" class="usa-link">Supporting Information</a> for additional details on variables.</p>
<figure class="fig xbox font-sm" id="pds70199-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bb/12358767/5ac89bf09595/PDS-34-e70199-g003.jpg" loading="lazy" id="jats-graphic-1" height="526" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/pds70199-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Illustration of the study design (ADE: adverse drug event, AKI: acute kidney injury, AMI: acute myocardial infarction, GI bleeding: gastrointestinal bleeding, opioid: opioid‐related ADE).</p></figcaption></figure></section><section id="pds70199-sec-0012"><h3 class="pmc_sec_title">2.2. Study Design and Analytical Datasets</h3>
<p>We used the matched case–control design to derive five analytical datasets for the five potential ADE outcomes. Without loss of generality, we described the methods to derive one analytical dataset. As described in Figure <a href="#pds70199-fig-0001" class="usa-link">1</a>, we defined cases as an individual's earliest known ED visit with the first and/or second diagnosis related to the potential ADE outcome. We excluded cases that had prior diagnoses related to the potential ADE outcome. We selected a control for each case matched on gender (exact), race (exact), risk factors (exact), age (±2 years), and year‐month of ED visit (±2 months), in which the matched controls also had no prior diagnosis related to the potential ADE outcome.</p>
<p>We defined the index dates as the ED visit dates for the cases and the matched controls. We assessed drug exposure data (e.g., drug name, quantity, dose [unit], and days of supply) within 30 days prior to the index dates (Figure <a href="#pds70199-fig-0001" class="usa-link">1</a>). We used RxNorm and the data source's drug name table to identify drug ingredient names, and to process the top‐200 most frequent drug ingredient names in cases [<a href="#pds70199-bib-0052" class="usa-link" aria-describedby="pds70199-bib-0052">52</a>]. Please note that one drug ingredient name might have more than one unit (e.g., milligram and percent for a drug available in both tablet and topical forms). For any drug ingredient name–unit combination, we defined the average daily dose (ADS) as (dose [unit] × quantity)/days of supply; and defined a numerical variable for drug dose (i.e., 0, 1, 2), which 0 represented no exposure (i.e., ADS = 0), 1 represented low dose exposure (i.e., 0 &lt; ADS ≤ median ADS in cases), and 2 represented high dose exposure (i.e., ADS &gt; median ADS in cases).</p>
<p>We derived five analytical datasets. Each dataset included the following data elements: ADE outcome status (case = 1 and control = 0), matched pair ID, variables for drug doses for the top‐200 most frequent drug ingredient name‐unit combinations in cases.</p></section><section id="pds70199-sec-0013"><h3 class="pmc_sec_title">2.3. Statistical Analyses</h3>
<p>We used the following conditional logistic regression model (CLRM) to screen three‐drug combinations (Equation <a href="#pds70199-disp-0001" class="usa-link">1</a>).</p>
<table class="disp-formula p" id="pds70199-disp-0001"><tr>
<td class="formula"><math id="jats-math-1" display="block" overflow="linebreak"><mrow><mrow><mtable><mtr><mtd columnalign="left"><mrow><mtext>logitProb</mtext><mfenced close=")" open="("><mrow><mi>ADE</mi><mo>=</mo><mn>1</mn></mrow></mfenced><mo>=</mo><mi>α</mi><mo>+</mo><msub><mi>β</mi><mn>1</mn></msub><msub><mi>X</mi><mn>1</mn></msub><mo>+</mo><msub><mi>β</mi><mn>2</mn></msub><msub><mi>X</mi><mn>2</mn></msub><mo>+</mo><msub><mi>β</mi><mn>3</mn></msub><msub><mi>X</mi><mn>3</mn></msub><mo>+</mo><msub><mi>β</mi><mn>4</mn></msub><mfenced close=")" open="("><mrow><msub><mi>X</mi><mn>1</mn></msub><mo>×</mo><msub><mi>X</mi><mn>2</mn></msub></mrow></mfenced></mrow></mtd></mtr><mtr><mtd columnalign="left"><mspace width="1em"></mspace><mrow><mo>+</mo><msub><mi>β</mi><mn>5</mn></msub><mfenced close=")" open="("><mrow><msub><mi>X</mi><mn>1</mn></msub><mo>×</mo><msub><mi>X</mi><mn>3</mn></msub></mrow></mfenced><mo>+</mo><msub><mi>β</mi><mn>6</mn></msub><mfenced close=")" open="("><mrow><msub><mi>X</mi><mn>2</mn></msub><mo>×</mo><msub><mi>X</mi><mn>3</mn></msub></mrow></mfenced><mo>+</mo><msub><mi>β</mi><mn>7</mn></msub><mfenced close=")" open="("><mrow><msub><mi>X</mi><mn>1</mn></msub><mo>×</mo><msub><mi>X</mi><mn>2</mn></msub><mo>×</mo><msub><mi>X</mi><mn>3</mn></msub></mrow></mfenced></mrow></mtd></mtr></mtable></mrow></mrow></math></td>
<td class="label">(1)</td>
</tr></table>
<p>In Equation (<a href="#pds70199-disp-0001" class="usa-link">1</a>), <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-2" display="inline" overflow="linebreak"><mrow><mrow><mi>X</mi></mrow></mrow></math></span>s were variables for drug doses (i.e., <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-3" display="inline" overflow="linebreak"><mrow><mrow><mi>X</mi></mrow></mrow></math></span> = 0, 1 or 2), <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-4" display="inline" overflow="linebreak"><mrow><mrow><mi>α</mi></mrow></mrow></math></span> was the random effect for the matched pair, and <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-5" display="inline" overflow="linebreak"><mrow><mrow><mi>β</mi></mrow></mrow></math></span> s were the log‐odds ratios (ORs).</p>
<p>As there were a large amount of three‐drug combinations, we tested three‐drug combinations that were frequent (<em>N</em> ≥ 500) in cases and related to the ADE outcome to maintain the statistical power. Specifically, for AKI, AMI and GI bleeding, the tested three‐drug combinations included at least one ADE‐related drug according to drug labels [<a href="#pds70199-bib-0053" class="usa-link" aria-describedby="pds70199-bib-0053">53</a>, <a href="#pds70199-bib-0054" class="usa-link" aria-describedby="pds70199-bib-0054">54</a>]. For hypoglycemia and opioid‐related ADE, the tested three‐drug combinations included at least one antidiabetic drug and opioid, respectively. The drugs in the tested three‐drug combinations were summarized in Table <a href="#pds70199-supitem-0002" class="usa-link">S1</a>. For each tested three‐drug combination, we estimated 7 parameters (i.e., <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-6" display="inline" overflow="linebreak"><mrow><mrow><mi>β</mi></mrow></mrow></math></span> s) under the CLRM (Equation <a href="#pds70199-disp-0001" class="usa-link">1</a>), seven <em>p</em> values for testing <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-7" display="inline" overflow="linebreak"><mrow><mrow><mi>β</mi></mrow></mrow></math></span>s ≤ 0, and one <em>p</em> value for testing log‐OR ≤ 0 given <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-8" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>1</mn></msub></mrow></mrow></math></span> = <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-9" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>2</mn></msub></mrow></mrow></math></span>= <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-10" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>3</mn></msub></mrow></mrow></math></span> = 2 (i.e., no increased risk under the highest dose level; Equation <a href="#pds70199-disp-0002" class="usa-link">2</a>). In other words, we computed eight <em>p</em> values for each three‐drug combination.</p>
<table class="disp-formula p" id="pds70199-disp-0002"><tr>
<td class="formula"><math id="jats-math-11" display="block" overflow="linebreak"><mrow><mrow><msub><mi>H</mi><mn>0</mn></msub><mo>:</mo><mn>2</mn><mspace width="0.25em"></mspace><msub><mi>β</mi><mn>1</mn></msub><mo linebreak="goodbreak">+</mo><mn>2</mn><mspace width="0.25em"></mspace><msub><mi>β</mi><mn>2</mn></msub><mo linebreak="goodbreak">+</mo><mn>2</mn><mspace width="0.25em"></mspace><msub><mi>β</mi><mn>3</mn></msub><mo linebreak="goodbreak">+</mo><mn>4</mn><mspace width="0.25em"></mspace><msub><mi>β</mi><mn>4</mn></msub><mo linebreak="goodbreak">+</mo><mn>4</mn><mspace width="0.25em"></mspace><msub><mi>β</mi><mn>5</mn></msub><mo linebreak="goodbreak">+</mo><mn>4</mn><mspace width="0.25em"></mspace><msub><mi>β</mi><mn>6</mn></msub><mo linebreak="goodbreak">+</mo><mn>8</mn><mspace width="0.25em"></mspace><msub><mi>β</mi><mn>7</mn></msub><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>¬</mo><msub><mi>H</mi><mn>0</mn></msub></mrow></mrow></math></td>
<td class="label">(2)</td>
</tr></table>
<p>We computed the Benjamini and Hochberg's false discovery rate (FDR) using all <em>p</em> values of all tested three‐drug combinations [<a href="#pds70199-bib-0055" class="usa-link" aria-describedby="pds70199-bib-0055">55</a>]. We selected the three‐drug combination associated with an increased risk under the highest dose level (e.g., Equation <a href="#pds70199-disp-0002" class="usa-link">2</a>); as well as included three potential risky individual drug effects and/or significant interaction effect(s). Please see <a href="#pds70199-supitem-0001" class="usa-link">Supporting Information</a> for additional details.</p>
<p>For signals, we investigated the relationship between reductions in dose (or exposure) and the risk of ADE. Under Equation (<a href="#pds70199-disp-0001" class="usa-link">1</a>), we estimated the ORs for the highest dose level (e.g., (<span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-12" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>1</mn></msub></mrow></mrow></math></span>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-13" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>2</mn></msub></mrow></mrow></math></span>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-14" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>3</mn></msub></mrow></mrow></math></span>) = (2,2,2)) and other dose levels (e.g., (<span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-15" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>1</mn></msub></mrow></mrow></math></span>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-16" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>2</mn></msub></mrow></mrow></math></span>, <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-17" display="inline" overflow="linebreak"><mrow><mrow><msub><mi>X</mi><mn>3</mn></msub></mrow></mrow></math></span>) <span xmlns:mml="http://www.w3.org/1998/Math/MathML"><math id="jats-math-18" display="inline" overflow="linebreak"><mrow><mrow><mo>≠</mo></mrow></mrow></math></span> (2,2,2)). We compared the highest dose level to other dose levels under <em>z</em>‐test (Equation <a href="#pds70199-disp-0003" class="usa-link">3</a>). We defined a significant risk reduction as <em>p</em> value &lt; 0.05.</p>
<table class="disp-formula p" id="pds70199-disp-0003"><tr>
<td class="formula"><math id="jats-math-19" display="block" overflow="linebreak"><mrow><mrow><mtable displaystyle="true"><mtr><mtd><mtext>Dose reduction for</mtext><mspace width="0.25em"></mspace><mi>one</mi><mspace width="0.25em"></mspace><mtext>drug</mtext><mo>:</mo></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>1</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mspace width="0.25em"></mspace><mi>β</mi><mn>3</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>1</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mspace width="0.25em"></mspace><mi>β</mi><mn>2</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>1</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mspace width="0.25em"></mspace><mi>β</mi><mn>1</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mtext>Dose reduction for</mtext><mspace width="0.25em"></mspace><mi>two</mi><mspace width="0.25em"></mspace><mtext>drugs</mtext><mo>:</mo></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>1</mn><mo>,</mo><mn>1</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mspace width="0.25em"></mspace><mi>β</mi><mn>2</mn><mo linebreak="goodbreak">+</mo><mi>β</mi><mn>3</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>3</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>6</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>1</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>1</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mspace width="0.25em"></mspace><mi>β</mi><mn>1</mn><mo linebreak="goodbreak">+</mo><mi>β</mi><mn>3</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>3</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>6</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>1</mn><mo>,</mo><mn>1</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mspace width="0.25em"></mspace><mi>β</mi><mn>1</mn><mo linebreak="goodbreak">+</mo><mi>β</mi><mn>2</mn><mo linebreak="goodbreak">+</mo><mn>3</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>2</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>6</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mtext>Dose reduction for three drugs</mtext><mo>:</mo></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>1</mn><mo>,</mo><mn>1</mn><mo>,</mo><mn>1</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mspace width="0.25em"></mspace><mi>β</mi><mn>1</mn><mo linebreak="goodbreak">+</mo><mi>β</mi><mn>2</mn><mo linebreak="goodbreak">+</mo><mi>β</mi><mn>3</mn><mo linebreak="goodbreak">+</mo><mn>3</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>3</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>3</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>7</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mtext>Exposure reduction for</mtext><mspace width="0.25em"></mspace><mi>one</mi><mspace width="0.25em"></mspace><mtext>drug</mtext><mo>:</mo></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>0</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mn>2</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>3</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>8</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>0</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mn>2</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>2</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mi>β</mi><mn>6</mn><mo linebreak="goodbreak">+</mo><mn>8</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd><mfenced close=")" open="("><mrow><mn>2</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mfenced close=")" open="("><mrow><mn>0</mn><mo>,</mo><mn>2</mn><mo>,</mo><mn>2</mn></mrow></mfenced><mo>:</mo><mtext>testing</mtext><mn>2</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>1</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mi>β</mi><mn>4</mn><mo linebreak="goodbreak">+</mo><mn>4</mn><mi>β</mi><mn>5</mn><mo linebreak="goodbreak">+</mo><mn>8</mn><mspace width="0.25em"></mspace><mi>β</mi><mn>7</mn><mo>≤</mo><mn>0</mn><mspace width="0.25em"></mspace><mi>vs</mi><mo>.</mo><mo>&gt;</mo><mn>0</mn></mtd></mtr></mtable></mrow></mrow></math></td>
<td class="label">(3)</td>
</tr></table>
<p>We also conducted subgroup analyses in individuals with age ≥ 65 years. All analyses were conducted in R.</p></section></section><section id="pds70199-sec-0014"><h2 class="pmc_sec_title">3. Results</h2>
<section id="pds70199-sec-0015"><h3 class="pmc_sec_title">3.1. Analytical Datasets and Signals of Adverse Three‐Drug Combinations</h3>
<p>Figure <a href="#pds70199-fig-0002" class="usa-link">2A</a> presents the demographics of the final analytical datasets. The numbers of matched pairs were 315 728 pairs for AKI, 243 045 pairs for AMI, 265 426 pairs for GI bleeding, 1 081 480 pairs for opioid‐related ADEs, and 51 551 pairs for hypoglycemia. As shown in Figure <a href="#pds70199-fig-0002" class="usa-link">2A</a>, most of the samples had White race and age ≥ 65 years, while 41%–53% of individuals were female. Figure <a href="#pds70199-fig-0002" class="usa-link">2B</a> presents the frequencies of all tested three‐drug combinations and signals of potential adverse three‐drug combinations. We identified over 500 signals out of approximately 3000 tested three‐drug combinations (false discovery rate [FDR] &lt; 0.05, Figure <a href="#pds70199-fig-0002" class="usa-link">2B</a>), in which most of the signals were associated with an increased risk of acute kidney injury (AKI). We observed that the ORs of the three drug combinations were highly consistent between overall analyses and older adult (age ≥ 65 years) subpopulation analyses. Table <a href="#pds70199-supitem-0002" class="usa-link">S2</a> includes all signals and their odds ratios under the different dose levels.</p>
<figure class="fig xbox font-sm" id="pds70199-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bb/12358767/12f5e4ca5842/PDS-34-e70199-g005.jpg" loading="lazy" id="jats-graphic-3" height="438" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/pds70199-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Demographics of the study population; (B) signals of potential adverse three‐drug combinations.</p></figcaption></figure></section><section id="pds70199-sec-0016"><h3 class="pmc_sec_title">3.2. Relationship Between Reduction in Drug Dose, Drug Exposure, and the Risk of ADE
</h3>
<p>Figure <a href="#pds70199-fig-0003" class="usa-link">3</a> illustrates the estimated ORs for the three‐drug combinations with respect to the highest dose level (e.g., dose &gt; threshold for 3 drugs), a lower dose for only one drug (e.g., dose &gt; threshold for 2 drugs, and 0 &lt; dose ≤ threshold for 1 drug), lower doses for two drugs (e.g., dose &gt; threshold for 1 drug, and 0 &lt; dose ≤ threshold for 2 drugs), and lower doses for three drugs (e.g., 0 &lt; dose ≤ threshold for 3 drugs). For signals of potential adverse three‐drug combinations, the medians were 3.04 for the highest dose level, 2.66 for a lower dose for only one drug, 2.27 for lower doses for two drugs, and 1.93 for lower doses for three drugs (Figure <a href="#pds70199-fig-0003" class="usa-link">3A</a>). For all tested three‐drug combinations, the medians were 1.94 for the highest dose level, 1.79 for a lower dose for only one drug, 1.63 for lower doses for two drugs, and 1.49 for lower doses for three drugs (Figure <a href="#pds70199-fig-0003" class="usa-link">3B</a>).</p>
<figure class="fig xbox font-sm" id="pds70199-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bb/12358767/5fe25a3008d8/PDS-34-e70199-g004.jpg" loading="lazy" id="jats-graphic-5" height="894" width="661" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/pds70199-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Distributions of odds ratios for the highest dose level, a lower dose for only one drug, lower doses for two drugs, and lower doses for three drugs; (A) signals; (B) all tested three‐drug combinations.</p></figcaption></figure><p>Figure <a href="#pds70199-fig-0004" class="usa-link">4</a> illustrates the potential relationship between dose levels of duloxetine‐hydrochlorothiazide‐oxycodone combination and ORs of opioid‐related ADE. Duloxetine‐hydrochlorothiazide‐oxycodone had OR = 4.74 under the highest dose level (e.g., duloxetine &gt; 60 mg/day, hydrochlorothiazide &gt; 25 mg/day, and oxycodone &gt; 40 mg/day). Compared with the highest dose level (OR = 4.74), the decrements of OR were 31%–46% (ORs: 2.54–3.28) for reducing the dose of one drug, 52%–69% (ORs: 1.47–2.27) for reducing the exposure of one drug (i.e., discontinuation of one drug), and 52%–65% (ORs: 1.66–2.26) for reducing the dose of two or more drugs (all <em>p</em> values &lt; 0.05).</p>
<figure class="fig xbox font-sm" id="pds70199-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bb/12358767/ddf605bbcd4c/PDS-34-e70199-g001.jpg" loading="lazy" id="jats-graphic-7" height="560" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/pds70199-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Relationship between dose of duloxetine‐hydrochlorothiazide‐oxycodone combination and odds ratios (ORs) of opioid‐related adverse drug events.</p></figcaption></figure><p>Figure <a href="#pds70199-fig-0005" class="usa-link">5</a> presents five examples of potential dose‐related reduction in ADE risk, while the estimated ADE risks for all signals under the highest dose level a lower dose for only one drug can be found in <a href="https://riskroute.shinyapps.io/doseroute/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://riskroute.shinyapps.io/doseroute/</a>. For AKI (Figure <a href="#pds70199-fig-0005" class="usa-link">5A</a>), the gabapentin‐hydrochlorothiazide‐oxycodone combination had an estimated OR = 5.34 under the strongest dose level (e.g., gabapentin &gt; 900 mg/day, hydrochlorothiazide &gt; 25 mg/day, and oxycodone &gt; 40 mg/day); and OR could be decreased by 29%–38% (ORs: 3.3–3.7) by reducing hydrochlorothiazide exposure to ≤ 25 mg/day or oxycodone exposure to ≤ 40 mg/day (all <em>p</em> values &lt; 0.05). For AMI (Figure <a href="#pds70199-fig-0005" class="usa-link">5B</a>), the glimepiride‐hydrochlorothiazide‐lisinopril combination had an estimated OR = 1.72 under the strongest dose level (e.g., glimepiride &gt; 4 mg/day, hydrochlorothiazide &gt; 25 mg/day, and lisinopril &gt; 20 mg/day); and OR could be decreased by 28% (OR = 1.23) by reducing glimepiride exposure to ≤ 5 mg/day (<em>p</em> values &lt; 0.05). For GI bleeding (Figure <a href="#pds70199-fig-0005" class="usa-link">5C</a>), the acetaminophen‐clopidogrel‐oxycodone combination had an estimated OR = 3.54 under the strongest dose level (e.g., acetaminophen &gt; 1300 mg/day, clopidogrel &gt; 75 mg/day, and oxycodone &gt; 3.75 mg/day); and OR could be decreased by 20%–43% (ORs: 2.03–2.82) by reducing any drug exposure to a lower dose (e.g., acetaminophen ≤ 1300 mg/day, clopidogrel ≤ 75 mg/day, or oxycodone ≤ 3.75 mg/day; all <em>p</em> values &lt; 0.05). For opioid‐related ADE (Figure <a href="#pds70199-fig-0004" class="usa-link">4D</a>), the gabapentin‐oxycodone‐zolpidem combination had OR = 3.10 under the strongest dose level (e.g., gabapentin &gt; 900 mg/day, oxycodone &gt; 40 mg/day, and zolpidem &gt; 10 mg/day); and OR could be decreased by 19%–25% (ORs: 2.31–2.50) by reducing oxycodone exposure to ≤ 40 mg/day or zolpidem exposure to ≤ 10 mg/day (all <em>p</em> values &lt; 0.05). For hypoglycemia (Figure <a href="#pds70199-fig-0005" class="usa-link">5E</a>), the atorvastatin‐glimepiride‐metformin combination had an estimated OR = 33.88 under the strongest dose level (e.g., atorvastatin &gt; 40 mg/day, glimepiride &gt; 4 mg/day, and metformin &gt; 2000 mg/day); and OR could be decreased by 58%–64% (ORs: 12.27–14.10) by reducing any drug exposure to a lower dose (e.g., atorvastatin ≤ 40 mg/day, glimepiride ≤ 4 mg/day, or metformin ≤ 2000 mg/day; all <em>p</em> values &lt; 0.05).</p>
<figure class="fig xbox font-sm" id="pds70199-fig-0005"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bb/12358767/6a3c571d10e9/PDS-34-e70199-g002.jpg" loading="lazy" id="jats-graphic-9" height="379" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/pds70199-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Relationship between dose of three‐drug combination and odds ratios (ORs) of adverse drug event (ADE); (A) Gabapentin‐hydrochlorothiazide‐oxycodone combination and acute kidney injury; (B) Glimepiride‐hydrochlorothiazide‐lisinopril combination and acute myocardial infarction; (C) Acetaminophen‐clopidogrel‐oxycodone combination and gastrointestinal bleeding; (D) Gabapentin‐oxycodone‐zolpidem combination and opioid‐related ADE; and (E) Atorvastatin‐glimepiride‐metformin combination and hypoglycemia.</p></figcaption></figure></section></section><section id="pds70199-sec-0017"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>In this study, we identified potential adverse three‐drug combinations from a large‐scale US nationwide health insurance claims data. We investigated five types of adverse drug events (ADEs) including acute kidney injury (AKI), acute myocardial infarction (AMI), gastrointestinal (GI) bleeding, hypoglycemia, and opioid‐related ADE. We further evaluated the relationship between reductions of drug dose, drug exposure, and the risk of ADE. We found many adverse three‐drug combinations had a potentially lower risk under lower dose levels compared with a high dose level.</p>
<p>Our study generates real‐world evidence on potential three‐drug combination‐induced ADE. More importantly, our study, compared with previous studies, derives novel knowledge on the relationship between dose of drug exposure and risk of ADE, which might be used to mitigate the burden of ADE. For instance, the duloxetine‐hydrochlorothiazide‐oxycodone combination is associated with an increased risk of opioid‐related ADE (Figure <a href="#pds70199-fig-0004" class="usa-link">4</a>). Besides oxycodone (an opioid), duloxetine (a central nervous system‐acting [CNS‐acting] drug for depression) is linked with sedation, and hydrochlorothiazide (a diuretic antihypertensive drug) is linked with dizziness [<a href="#pds70199-bib-0056" class="usa-link" aria-describedby="pds70199-bib-0056">56</a>, <a href="#pds70199-bib-0057" class="usa-link" aria-describedby="pds70199-bib-0057">57</a>], both of which could adversely affect the risk and symptoms of opioid‐related ADE. In our study, compared with all three drugs at a high dose level (e.g., duloxetine &gt; 60 mg/day, hydrochlorothiazide &gt; 25 mg/day, and oxycodone &gt; 40 mg/day), the odds ratio (OR) of ADE could potentially be decreased by 31%–46% by reducing the dose of one drug without any drug discontinuation, or potentially decreased by 52%–69% by reducing the dose of ≥ 2 drugs or discontinuing one drug (Figure <a href="#pds70199-fig-0004" class="usa-link">4</a>). These exposure‐ and dose‐specific ORs could be used to guide dosage adjustment and drug discontinuation or initiation for mitigating the ADE burden. Additionally, other than concomitant CNS‐acting drugs, our results suggest common drugs linked with dizziness could also be a risk factor for opioid‐related ADE.</p>
<p>We would like to discuss several additional examples. Gabapentin‐hydrochlorothiazide‐oxycodone combination is associated with an increased risk of AKI (Figure <a href="#pds70199-fig-0005" class="usa-link">5A</a>). Hydrochlorothiazide (a diuretic antihypertensive drug) could cause AKI and dehydration [<a href="#pds70199-bib-0058" class="usa-link" aria-describedby="pds70199-bib-0058">58</a>, <a href="#pds70199-bib-0059" class="usa-link" aria-describedby="pds70199-bib-0059">59</a>]. Oxycodone (an opioid) could also cause AKI due to dehydration [<a href="#pds70199-bib-0060" class="usa-link" aria-describedby="pds70199-bib-0060">60</a>]. Gabapentin is eliminated in the kidney and has been reported to cause AKI [<a href="#pds70199-bib-0061" class="usa-link" aria-describedby="pds70199-bib-0061">61</a>]. In our study, compared with all three drugs at a high dose level (e.g., for gabapentin &gt; 900 mg/day, hydrochlorothiazide &gt; 25 mg/day, and oxycodone &gt; 40 mg/day), the risk of ADE could be potentially decreased by 29%–38% by reducing the hydrochlorothiazide dose to ≤ 25 mg/day or the oxycodone dose to ≤ 40 mg/day. Our results suggested more considerations on drug dose and hydration status should be given for concomitant diuretic and opioid exposure, especially for patients with additional kidney‐eliminated drugs.</p>
<p>Moreover, as shown in Figure <a href="#pds70199-fig-0005" class="usa-link">5B–E</a>, glimepiride‐hydrochlorothiazide‐lisinopril combination, acetaminophen‐clopidogrel‐oxycodone combination, gabapentin‐oxycodone‐zolpidem combination, and atorvastatin‐glimepiride‐metformin combination are associated with increased risks for different types of ADEs. All of these drug combinations include at least one drug that has been linked to the corresponding ADE [<a href="#pds70199-bib-0053" class="usa-link" aria-describedby="pds70199-bib-0053">53</a>, <a href="#pds70199-bib-0054" class="usa-link" aria-describedby="pds70199-bib-0054">54</a>]. For instance, atorvastatin‐glimepiride‐metformin combination is associated with an increased risk of hypoglycemia. Atorvastatin could increase the risk of hypoglycemia at a higher dose [<a href="#pds70199-bib-0062" class="usa-link" aria-describedby="pds70199-bib-0062">62</a>], and glimepiride and metformin could cause hypoglycemia [<a href="#pds70199-bib-0053" class="usa-link" aria-describedby="pds70199-bib-0053">53</a>]. For these potential adverse three‐drug combinations, our results further reveal the relationship between dose of exposure and the risk of ADE. Compared with a high dose level of all three drugs, our study identifies the risk of ADE could be potentially decreased by 19%–64% by reducing the dose of one drug without any drug discontinuation. These findings suggest careful considerations on drug dose could mitigate the ADE burden. Additionally, more considerations on drug dose should be given for these potential adverse three‐drug combinations.</p>
<p>Our study also has several limitations related to real‐world data mining. First, as our analyses are based on US individuals with commercial health insurance or Medicare Advantage plans, our results might not be generalizable to other populations. Younger individuals with and without commercial health insurance may have differential health and socioeconomic statuses, as well as older individuals with and without Medicare Advantage plans. As both health status and socioeconomic status are linked to ADE risk [<a href="#pds70199-bib-0063" class="usa-link" aria-describedby="pds70199-bib-0063">63</a>], further studies are warranted to investigate the ADE risk in uninsured individuals, older adults without a Medicare Advantage plan, and socioeconomic status‐specific subpopulations. Second, we largely assume insurance records and claims are consistent with true clinical outcomes and drug exposure. However, ADE status and drug exposure could be misclassified in our analyses. We define a case as an emergency department (ED) visit with an ADE‐related diagnosis code in the first or second position. We focus on ED visits as the associations in an ED‐specific setting could better inform clinical decision making in an ED setting, especially given more than one million serious ADEs resulting in ED visits in the US each year [<a href="#pds70199-bib-0064" class="usa-link" aria-describedby="pds70199-bib-0064">64</a>]. Recent studies have found a high positive predictive value (PPV) for using diagnosis codes to define cardiovascular outcomes (e.g., PPVs ≥ 90% for the first diagnosis position, and ≥ 70% for both first and second diagnosis positions) [<a href="#pds70199-bib-0065" class="usa-link" aria-describedby="pds70199-bib-0065">65</a>, <a href="#pds70199-bib-0066" class="usa-link" aria-describedby="pds70199-bib-0066">66</a>]. As a higher PPV is associated with reduced sensitivity, we define cases by using both the first and second diagnosis positions to balance PPV and sensitivity. Our study includes ED visits regardless of whether the corresponding patients are discharged or hospitalized after ED visits. Further studies are warranted to investigate the associations between drug exposure and hospitalizations following ED visits. Third, we collect drug exposure data within 30 days prior to the cases' and controls' index dates. The 30‐day exposure window has been used to identify clinically meaningful adverse drug combinations [<a href="#pds70199-bib-0015" class="usa-link" aria-describedby="pds70199-bib-0015">15</a>, <a href="#pds70199-bib-0016" class="usa-link" aria-describedby="pds70199-bib-0016">16</a>, <a href="#pds70199-bib-0017" class="usa-link" aria-describedby="pds70199-bib-0017">17</a>]. However, we cannot fully ensure the temporality between drug exposure and ADE onset. Our analyses do not differentiate patients with and without long‐term exposure and might have suboptimal power to detect drugs with a time of exposure‐dependent risk of ADE [<a href="#pds70199-bib-0067" class="usa-link" aria-describedby="pds70199-bib-0067">67</a>].</p>
<p>Our analyses are subject to unmeasured confounding effects, especially for confounding by indication and/or disease severity. The observed associations might be confounded by disease severity and/or treatment indication. For instance, high dose compared with low dose of atorvastatin‐glimepiride‐metformin exposure is associated with a higher risk of hypoglycemia (Figure <a href="#pds70199-fig-0005" class="usa-link">5E</a>). Atorvastatin can manage hyperlipidemia, and glimepiride and metformin are diabetic drugs. Despite all of atorvastatin, glimepiride, and metformin being able to increase the risk of hypoglycemia at a higher dose level [<a href="#pds70199-bib-0053" class="usa-link" aria-describedby="pds70199-bib-0053">53</a>, <a href="#pds70199-bib-0054" class="usa-link" aria-describedby="pds70199-bib-0054">54</a>, <a href="#pds70199-bib-0062" class="usa-link" aria-describedby="pds70199-bib-0062">62</a>]; patients using higher doses of glimepiride and metformin may also have a greater severity of diabetes, which could increase the risk of hypoglycemia. Additionally, high dose compared with low dose of gabapentin‐hydrochlorothiazide‐oxycodone exposure is associated with a higher risk of AKI (Figure <a href="#pds70199-fig-0005" class="usa-link">5A</a>). Gabapentin can manage epilepsy, hydrochlorothiazide can manage hypertension, and oxycodone can be used to manage cancer‐related pain. While all of gabapentin, hydrochlorothiazide, and oxycodone are linked to AKI [<a href="#pds70199-bib-0058" class="usa-link" aria-describedby="pds70199-bib-0058">58</a>, <a href="#pds70199-bib-0059" class="usa-link" aria-describedby="pds70199-bib-0059">59</a>, <a href="#pds70199-bib-0060" class="usa-link" aria-describedby="pds70199-bib-0060">60</a>, <a href="#pds70199-bib-0061" class="usa-link" aria-describedby="pds70199-bib-0061">61</a>], their indications (e.g., epilepsy, hypertension, and cancer) could also increase the risk of AKI [<a href="#pds70199-bib-0043" class="usa-link" aria-describedby="pds70199-bib-0043">43</a>, <a href="#pds70199-bib-0044" class="usa-link" aria-describedby="pds70199-bib-0044">44</a>, <a href="#pds70199-bib-0068" class="usa-link" aria-describedby="pds70199-bib-0068">68</a>, <a href="#pds70199-bib-0069" class="usa-link" aria-describedby="pds70199-bib-0069">69</a>]. Moreover, certain measurements (e.g., weight, creatinine, low‐density lipoprotein [LDL], hemoglobin A1c [HbA1c], etc.) could be linked with both the dose of drug exposure and the risk of ADE, while these variables are unavailable in our datasets. Additionally, weight could also relate to the dose of certain drugs and risks of ADEs. Given these limitations, our findings cannot be interpreted as causality. We expect future studies to validate our findings and further illuminate the mechanisms between the dose of three‐drug combination exposure and the risk of ADE. Clinical study or observational study using a perspective cohort design could be used to estimate the incidence and comparative risks between high‐dose and low‐dose exposure of three‐drug combinations. Additionally, a physiologically based pharmacokinetic model and quantitative system pharmacology model can validate the relationship between the dose of exposure and the risk of ADE.</p>
<p>Moreover, as the dose of drug exposure is related to both efficacy and toxicity, we expect future studies to evaluate the relationship between dose of exposure, risk of ADE, and efficacy. As the risk of potential adverse three‐drug combination could be reduced in multiple ways (Figures <a href="#pds70199-fig-0004" class="usa-link">4</a> and <a href="#pds70199-fig-0005" class="usa-link">5</a>), we hypothesize the optimal dose of three‐drug combination can be derived to optimize the benefit–risk ratio. Finally, the median drug dose in the dataset is used as the cutoff for low versus high dose without consideration for clinical implications. This may limit clinical applicability, as our results were not reviewed for clinical applicability. We use median doses as thresholds under a rationale of high‐throughput data mining. By comparing our thresholds to the recommended doses defined in <a href="http://drugs.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">drugs.com</a>, we find our thresholds could be meaningful. Using the duloxetine‐hydrochlorothiazide‐hydrocodone combination as an example (Figure <a href="#pds70199-fig-0004" class="usa-link">4</a>), the median doses in our study and the recommended doses in <a href="http://drugs.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">drugs.com</a> are: (i) duloxetine =60 mg/day in our study, and 40–120 mg/day for depression in <a href="http://drugs.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">drugs.com</a> [<a href="#pds70199-bib-0070" class="usa-link" aria-describedby="pds70199-bib-0070">70</a>]; (ii) hydrochlorothiazide = 25 mg/day in our study, and 25–50 mg/day for hypertension in <a href="http://drugs.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">drugs.com</a> [<a href="#pds70199-bib-0071" class="usa-link" aria-describedby="pds70199-bib-0071">71</a>]; and (iii) hydrocodone =40 mg/day in our study, and 20–80 mg/day for chronic pain in <a href="http://drugs.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">drugs.com</a> [<a href="#pds70199-bib-0072" class="usa-link" aria-describedby="pds70199-bib-0072">72</a>]. Our methods can be applied to more clinically meaningful thresholds, while doing so requires clinical and pharmacological expertise with respect to a significant amount of drugs and adverse drug events (ADEs).</p>
<p>In conclusion, we identify potential adverse three‐drug combinations associated with an increased risk of ADE, and relationships between the dose of three‐drug combination exposure and the risk of ADE. Our analyses suggest careful consideration of drug dose could mitigate the ADE burden among patients using multiple drugs.</p></section><section id="pds70199-sec-0019"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>All authors participated in the design of the project, interpretation of results, and the critical writing and editing of the manuscript. Y.S., A.S., C.W.C., and P.Z. also participated in the data analyses.</p></section><section id="pds70199-sec-0018"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The Indiana University Institutional Review Boards (IRBs) designated this study as exempt.</p></section><section id="pds70199-sec-0021"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="sec18"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pds70199-supitem-0001"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12358767/bin/PDS-34-e70199-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">PDS-34-e70199-s001.docx</a><sup> (26.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pds70199-supitem-0002"><div class="caption p">
<p>
<strong>Table S1:</strong> drugs in the tested three‐drug combinations.</p>
<p>
<strong>Table S2:</strong> Signals of adverse three‐drug combinations. High level: dose &gt; Cutoff; Low level: 0 &lt; dose ≤ Cutoff; OR: odds ratio compared with no exposure; P: <em>p</em> value for testing a significant risk reduction compared with the highest dose under <em>z</em>‐test; 222: doses of all three drugs at the highest level; 122/212/221: reducing dose of Drug_1/Drug_2/Drug_3 to low level; 112/121/211: reducing doses of Drug_1 and Drug 2/Drug_1 and Drug_3/Drug_2 and Drug_3 to low level; 022/202/220: discontinue of Drug_1/Drug_2/Drug_3; 111: reducing doses of all three drugs to low level.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12358767/bin/PDS-34-e70199-s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">PDS-34-e70199-s002.xlsx</a><sup> (97.2KB, xlsx) </sup>
</div></div></section></section><section id="pds70199-sec-0020" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors have nothing to report.</p></section><section id="notes1"><p>

Shi Y., Sun A., Chiang C. W., et al., “Potential Drug Dose‐Specific Adverse Three‐Drug Combinations: A US Insurance Claims Data‐Based Study,” Pharmacoepidemiology and Drug Safety
34, no. 9 (2025): e70199, 10.1002/pds.70199.
</p>
<section id="pds70199-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="pds70199-note-0001"><p>
<strong>Funding:</strong> This work was supported by the NIH (R01LM013771, R01AG071018, and R01GM141279).</p></div></div></section></section><section id="pds70199-sec-0023"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Optum's de‐identified Clinformatics Data Mart Database is not publicly available (accessibility can be obtained from Optum: <a href="http://optum.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">optum.com</a>). Summary statistics generated during this study are included in this published article and its <a href="#pds70199-supitem-0001" class="usa-link">Supporting Information</a> files.</p></section><section id="pds70199-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="pds70199-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pds70199-bib-0001">
<span class="label">1.</span><cite>
Centers for Disease Control and Prevention (CDC)
, “Prescription Drug Use in the Past 30 Days, by Sex, Race and Hispanic Origin, and Age: United States, Selected Years 1988–1994 Through 2015–2018. National Center for Health Statistics,”
<a href="https://www.cdc.gov/nchs/data/hus/2019/039-508.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">chrome‐extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.cdc.gov/nchs/data/hus/2019/039‐508.pdf</a>.</cite>
</li>
<li id="pds70199-bib-0002">
<span class="label">2.</span><cite>
Bernell S. and Howard S. W., “Use Your Words Carefully: What Is a Chronic Disease?,” Frontiers in Public Health
4 (2016): 159, 10.3389/fpubh.2016.00159.
</cite> [<a href="https://doi.org/10.3389/fpubh.2016.00159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4969287/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27532034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Public%20Health&amp;title=Use%20Your%20Words%20Carefully:%20What%20Is%20a%20Chronic%20Disease?&amp;author=S.%20Bernell&amp;author=S.%20W.%20Howard&amp;volume=4&amp;publication_year=2016&amp;pages=159&amp;pmid=27532034&amp;doi=10.3389/fpubh.2016.00159&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0003">
<span class="label">3.</span><cite>
Kontis V., Bennett J. E., Mathers C. D., Li G., Foreman K., and Ezzati M., “Future Life Expectancy in 35 Industrialised Countries: Projections With a Bayesian Model Ensemble,” Lancet
389, no. 10076 (2017): 1323–1335, 10.1016/S0140-6736(16)32381-9.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)32381-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5387671/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28236464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Future%20Life%20Expectancy%20in%2035%20Industrialised%20Countries:%20Projections%20With%20a%20Bayesian%20Model%20Ensemble&amp;author=V.%20Kontis&amp;author=J.%20E.%20Bennett&amp;author=C.%20D.%20Mathers&amp;author=G.%20Li&amp;author=K.%20Foreman&amp;volume=389&amp;issue=10076&amp;publication_year=2017&amp;pages=1323-1335&amp;pmid=28236464&amp;doi=10.1016/S0140-6736(16)32381-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0004">
<span class="label">4.</span><cite>
Davies L. E., Spiers G., Kingston A., Todd A., Adamson J., and Hanratty B., “Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews,” Journal of the American Medical Directors Association
21, no. 2 (February 2020): 181–187, 10.1016/j.jamda.2019.10.022.
</cite> [<a href="https://doi.org/10.1016/j.jamda.2019.10.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31926797/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Medical%20Directors%20Association&amp;title=Adverse%20Outcomes%20of%20Polypharmacy%20in%20Older%20People:%20Systematic%20Review%20of%20Reviews&amp;author=L.%20E.%20Davies&amp;author=G.%20Spiers&amp;author=A.%20Kingston&amp;author=A.%20Todd&amp;author=J.%20Adamson&amp;volume=21&amp;issue=2&amp;publication_year=February%202020&amp;pages=181-187&amp;pmid=31926797&amp;doi=10.1016/j.jamda.2019.10.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0005">
<span class="label">5.</span><cite>
Halli‐Tierney A. D., Scarbrough C., and Carroll D., “Polypharmacy: Evaluating Risks and Deprescribing,” American Family Physician
100, no. 1 (July 2019): 32–38.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/31259501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Family%20Physician&amp;title=Polypharmacy:%20Evaluating%20Risks%20and%20Deprescribing&amp;author=A.%20D.%20Halli%E2%80%90Tierney&amp;author=C.%20Scarbrough&amp;author=D.%20Carroll&amp;volume=100&amp;issue=1&amp;publication_year=July%202019&amp;pages=32-38&amp;pmid=31259501&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0006">
<span class="label">6.</span><cite>
Sommer J., Viviani R., Wozniak J., Stingl J. C., and Just K. S., “Dealing With Adverse Drug Reactions in the Context of Polypharmacy Using Regression Models,” Scientific Reports
14, no. 1 (2024): 27355, 10.1038/s41598-024-78474-4.
</cite> [<a href="https://doi.org/10.1038/s41598-024-78474-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11550797/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39521861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Dealing%20With%20Adverse%20Drug%20Reactions%20in%20the%20Context%20of%20Polypharmacy%20Using%20Regression%20Models&amp;author=J.%20Sommer&amp;author=R.%20Viviani&amp;author=J.%20Wozniak&amp;author=J.%20C.%20Stingl&amp;author=K.%20S.%20Just&amp;volume=14&amp;issue=1&amp;publication_year=2024&amp;pages=27355&amp;pmid=39521861&amp;doi=10.1038/s41598-024-78474-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0007">
<span class="label">7.</span><cite>
Ye L., Yang‐Huang J., Franse C. B., et al., “Factors Associated With Polypharmacy and the High Risk of Medication‐Related Problems Among Older Community‐Dwelling Adults in European Countries: A Longitudinal Study,” BMC Geriatrics
22, no. 1 (2022): 841, 10.1186/s12877-022-03536-z.
</cite> [<a href="https://doi.org/10.1186/s12877-022-03536-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9641844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36344918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Geriatrics&amp;title=Factors%20Associated%20With%20Polypharmacy%20and%20the%20High%20Risk%20of%20Medication%E2%80%90Related%20Problems%20Among%20Older%20Community%E2%80%90Dwelling%20Adults%20in%20European%20Countries:%20A%20Longitudinal%20Study&amp;author=L.%20Ye&amp;author=J.%20Yang%E2%80%90Huang&amp;author=C.%20B.%20Franse&amp;volume=22&amp;issue=1&amp;publication_year=2022&amp;pages=841&amp;pmid=36344918&amp;doi=10.1186/s12877-022-03536-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0008">
<span class="label">8.</span><cite>
Lau S. W. J., Huang Y., Hsieh J., et al., “Participation of Older Adults in Clinical Trials for New Drug Applications and Biologics License Applications From 2010 Through 2019,” JAMA Network Open
5, no. 10 (October 2022): e2236149, 10.1001/jamanetworkopen.2022.36149.
</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2022.36149" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9568796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36239939/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Network%20Open&amp;title=Participation%20of%20Older%20Adults%20in%20Clinical%20Trials%20for%20New%20Drug%20Applications%20and%20Biologics%20License%20Applications%20From%202010%20Through%202019&amp;author=S.%20W.%20J.%20Lau&amp;author=Y.%20Huang&amp;author=J.%20Hsieh&amp;volume=5&amp;issue=10&amp;publication_year=October%202022&amp;pages=e2236149&amp;pmid=36239939&amp;doi=10.1001/jamanetworkopen.2022.36149&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0009">
<span class="label">9.</span><cite>
Ruiter R., Burggraaf J., and Rissmann R., “Under‐Representation of Elderly in Clinical Trials: An Analysis of the Initial Approval Documents in the Food and Drug Administration Database,” British Journal of Clinical Pharmacology
85, no. 4 (April 2019): 838–844, 10.1111/bcp.13876.
</cite> [<a href="https://doi.org/10.1111/bcp.13876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6422639/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30681181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=Under%E2%80%90Representation%20of%20Elderly%20in%20Clinical%20Trials:%20An%20Analysis%20of%20the%20Initial%20Approval%20Documents%20in%20the%20Food%20and%20Drug%20Administration%20Database&amp;author=R.%20Ruiter&amp;author=J.%20Burggraaf&amp;author=R.%20Rissmann&amp;volume=85&amp;issue=4&amp;publication_year=April%202019&amp;pages=838-844&amp;pmid=30681181&amp;doi=10.1111/bcp.13876&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0010">
<span class="label">10.</span><cite>
Tan Y. Y., Papez V., Chang W. H., Mueller S. H., Denaxas S., and Lai A. G., “Comparing Clinical Trial Population Representativeness to Real‐World Populations: An External Validity Analysis Encompassing 43 895 Trials and 5 685 738 Individuals Across 989 Unique Drugs and 286 Conditions in England,” Lancet Healthy Longevity
3, no. 10 (2022): e674–e689, 10.1016/S2666-7568(22)00186-6.
</cite> [<a href="https://doi.org/10.1016/S2666-7568(22)00186-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36150402/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Healthy%20Longevity&amp;title=Comparing%20Clinical%20Trial%20Population%20Representativeness%20to%20Real%E2%80%90World%20Populations:%20An%20External%20Validity%20Analysis%20Encompassing%2043%20895%20Trials%20and%205%20685%20738%20Individuals%20Across%20989%20Unique%20Drugs%20and%20286%20Conditions%20in%20England&amp;author=Y.%20Y.%20Tan&amp;author=V.%20Papez&amp;author=W.%20H.%20Chang&amp;author=S.%20H.%20Mueller&amp;author=S.%20Denaxas&amp;volume=3&amp;issue=10&amp;publication_year=2022&amp;pages=e674-e689&amp;pmid=36150402&amp;doi=10.1016/S2666-7568(22)00186-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0011">
<span class="label">11.</span><cite>
van Marum R. J., “Underrepresentation of the Elderly in Clinical Trials, Time for Action,” British Journal of Clinical Pharmacology
86, no. 10 (October 2020): 2014–2016, 10.1111/bcp.14539.
</cite> [<a href="https://doi.org/10.1111/bcp.14539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7495271/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32909294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=Underrepresentation%20of%20the%20Elderly%20in%20Clinical%20Trials,%20Time%20for%20Action&amp;author=R.%20J.%20van%20Marum&amp;volume=86&amp;issue=10&amp;publication_year=October%202020&amp;pages=2014-2016&amp;pmid=32909294&amp;doi=10.1111/bcp.14539&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0012">
<span class="label">12.</span><cite>
Ellenbogen M. I., Wang P., Overton H. N., et al., “Frequency and Predictors of Polypharmacy in US Medicare Patients: A Cross‐Sectional Analysis at the Patient and Physician Levels,” Drugs &amp; Aging
37, no. 1 (January 2020): 57–65, 10.1007/s40266-019-00726-0.
</cite> [<a href="https://doi.org/10.1007/s40266-019-00726-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31782129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drugs%20&amp;%20Aging&amp;title=Frequency%20and%20Predictors%20of%20Polypharmacy%20in%20US%20Medicare%20Patients:%20A%20Cross%E2%80%90Sectional%20Analysis%20at%20the%20Patient%20and%20Physician%20Levels&amp;author=M.%20I.%20Ellenbogen&amp;author=P.%20Wang&amp;author=H.%20N.%20Overton&amp;volume=37&amp;issue=1&amp;publication_year=January%202020&amp;pages=57-65&amp;pmid=31782129&amp;doi=10.1007/s40266-019-00726-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0013">
<span class="label">13.</span><cite>
Acton E. K., Hennessy S., Gelfand M. A., et al., “Thinking Three‐Dimensionally: A Self‐ and Externally‐Controlled Approach to Screening for Drug‐Drug‐Drug Interactions Among High‐Risk Populations,” Clinical Pharmacology and Therapeutics
116, no. 2 (August 2024): 448–459, 10.1002/cpt.3310.
</cite> [<a href="https://doi.org/10.1002/cpt.3310" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11262479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38860403/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20and%20Therapeutics&amp;title=Thinking%20Three%E2%80%90Dimensionally:%20A%20Self%E2%80%90%20and%20Externally%E2%80%90Controlled%20Approach%20to%20Screening%20for%20Drug%E2%80%90Drug%E2%80%90Drug%20Interactions%20Among%20High%E2%80%90Risk%20Populations&amp;author=E.%20K.%20Acton&amp;author=S.%20Hennessy&amp;author=M.%20A.%20Gelfand&amp;volume=116&amp;issue=2&amp;publication_year=August%202024&amp;pages=448-459&amp;pmid=38860403&amp;doi=10.1002/cpt.3310&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0014">
<span class="label">14.</span><cite>
Shi Y., Chiang C. W., Unroe K. T., et al., “Application of an Innovative Data Mining Approach Towards Safe Polypharmacy Practice in Older Adults,” Drug Safety
47, no. 1 (January 2024): 93–102, 10.1007/s40264-023-01370-9.
</cite> [<a href="https://doi.org/10.1007/s40264-023-01370-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11256269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37935996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Drug%20Safety&amp;title=Application%20of%20an%20Innovative%20Data%20Mining%20Approach%20Towards%20Safe%20Polypharmacy%20Practice%20in%20Older%20Adults&amp;author=Y.%20Shi&amp;author=C.%20W.%20Chiang&amp;author=K.%20T.%20Unroe&amp;volume=47&amp;issue=1&amp;publication_year=January%202024&amp;pages=93-102&amp;pmid=37935996&amp;doi=10.1007/s40264-023-01370-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0015">
<span class="label">15.</span><cite>
Bykov K., Schneeweiss S., Glynn R. J., Mittleman M. A., and Gagne J. J., “A Case‐Crossover‐Based Screening Approach to Identifying Clinically Relevant Drug‐Drug Interactions in Electronic Healthcare Data,” Clinical Pharmacology and Therapeutics
106, no. 1 (July 2019): 238–244, 10.1002/cpt.1376.
</cite> [<a href="https://doi.org/10.1002/cpt.1376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30663781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20and%20Therapeutics&amp;title=A%20Case%E2%80%90Crossover%E2%80%90Based%20Screening%20Approach%20to%20Identifying%20Clinically%20Relevant%20Drug%E2%80%90Drug%20Interactions%20in%20Electronic%20Healthcare%20Data&amp;author=K.%20Bykov&amp;author=S.%20Schneeweiss&amp;author=R.%20J.%20Glynn&amp;author=M.%20A.%20Mittleman&amp;author=J.%20J.%20Gagne&amp;volume=106&amp;issue=1&amp;publication_year=July%202019&amp;pages=238-244&amp;pmid=30663781&amp;doi=10.1002/cpt.1376&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0016">
<span class="label">16.</span><cite>
Chiang C. W., Zhang P., Wang X., et al., “Translational High‐Dimensional Drug Interaction Discovery and Validation Using Health Record Databases and Pharmacokinetics Models,” Clinical Pharmacology and Therapeutics
103, no. 2 (February 2018): 287–295, 10.1002/cpt.914.
</cite> [<a href="https://doi.org/10.1002/cpt.914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29052226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Pharmacology%20and%20Therapeutics&amp;title=Translational%20High%E2%80%90Dimensional%20Drug%20Interaction%20Discovery%20and%20Validation%20Using%20Health%20Record%20Databases%20and%20Pharmacokinetics%20Models&amp;author=C.%20W.%20Chiang&amp;author=P.%20Zhang&amp;author=X.%20Wang&amp;volume=103&amp;issue=2&amp;publication_year=February%202018&amp;pages=287-295&amp;pmid=29052226&amp;doi=10.1002/cpt.914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0017">
<span class="label">17.</span><cite>
Du L., Chakraborty A., Chiang C. W., et al., “Graphic Mining of High‐Order Drug Interactions and Their Directional Effects on Myopathy Using Electronic Medical Records,” CPT: Pharmacometrics &amp; Systems Pharmacology
4, no. 8 (August 2015): 481–488, 10.1002/psp4.59.
</cite> [<a href="https://doi.org/10.1002/psp4.59" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4562164/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26380157/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=CPT:%20Pharmacometrics%20&amp;%20Systems%20Pharmacology&amp;title=Graphic%20Mining%20of%20High%E2%80%90Order%20Drug%20Interactions%20and%20Their%20Directional%20Effects%20on%20Myopathy%20Using%20Electronic%20Medical%20Records&amp;author=L.%20Du&amp;author=A.%20Chakraborty&amp;author=C.%20W.%20Chiang&amp;volume=4&amp;issue=8&amp;publication_year=August%202015&amp;pages=481-488&amp;pmid=26380157&amp;doi=10.1002/psp4.59&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0018">
<span class="label">18.</span><cite>
Wang X. Y., Zhang P. Y., Chiang C. W., et al., “Mixture Drug‐Count Response Model for the High‐Dimensional Drug Combinatory Effect on Myopathy,” Statistics in Medicine
37, no. 4 (February 2018): 673–686, 10.1002/sim.7545.
</cite> [<a href="https://doi.org/10.1002/sim.7545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5771837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29171062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Statistics%20in%20Medicine&amp;title=Mixture%20Drug%E2%80%90Count%20Response%20Model%20for%20the%20High%E2%80%90Dimensional%20Drug%20Combinatory%20Effect%20on%20Myopathy&amp;author=X.%20Y.%20Wang&amp;author=P.%20Y.%20Zhang&amp;author=C.%20W.%20Chiang&amp;volume=37&amp;issue=4&amp;publication_year=February%202018&amp;pages=673-686&amp;pmid=29171062&amp;doi=10.1002/sim.7545&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0019">
<span class="label">19.</span><cite>
Yao X., Tsang T., Sun Q., et al., “Mining and Visualizing High‐Order Directional Drug Interaction Effects Using the FAERS Database,” BMC Medical Informatics and Decision Making
20, no. Suppl 2 (March 2020): 50, 10.1186/s12911-020-1053-z.
</cite> [<a href="https://doi.org/10.1186/s12911-020-1053-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7079342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32183790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Medical%20Informatics%20and%20Decision%20Making&amp;title=Mining%20and%20Visualizing%20High%E2%80%90Order%20Directional%20Drug%20Interaction%20Effects%20Using%20the%20FAERS%20Database&amp;author=X.%20Yao&amp;author=T.%20Tsang&amp;author=Q.%20Sun&amp;volume=20&amp;issue=Suppl%202&amp;publication_year=March%202020&amp;pages=50&amp;pmid=32183790&amp;doi=10.1186/s12911-020-1053-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0020">
<span class="label">20.</span><cite>
Acton E. K., Hennessy S., Brensinger C. M., et al., “Opioid Drug‐Drug‐Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three‐Way Drug Interaction Signals,” Frontiers in Pharmacology
13 (2022): 845485, 10.3389/fphar.2022.845485.
</cite> [<a href="https://doi.org/10.3389/fphar.2022.845485" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9127150/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35620282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Opioid%20Drug%E2%80%90Drug%E2%80%90Drug%20Interactions%20and%20Unintentional%20Traumatic%20Injury:%20Screening%20to%20Detect%20Three%E2%80%90Way%20Drug%20Interaction%20Signals&amp;author=E.%20K.%20Acton&amp;author=S.%20Hennessy&amp;author=C.%20M.%20Brensinger&amp;volume=13&amp;publication_year=2022&amp;pages=845485&amp;pmid=35620282&amp;doi=10.3389/fphar.2022.845485&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0021">
<span class="label">21.</span><cite>
Chen C., Hennessy S., Brensinger C. M., et al., “Population‐Based Screening to Detect Benzodiazepine Drug‐Drug‐Drug Interaction Signals Associated With Unintentional Traumatic Injury,” Scientific Reports
12, no. 1 (September 2022): 15569, 10.1038/s41598-022-19551-4.
</cite> [<a href="https://doi.org/10.1038/s41598-022-19551-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9481644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36114250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Population%E2%80%90Based%20Screening%20to%20Detect%20Benzodiazepine%20Drug%E2%80%90Drug%E2%80%90Drug%20Interaction%20Signals%20Associated%20With%20Unintentional%20Traumatic%20Injury&amp;author=C.%20Chen&amp;author=S.%20Hennessy&amp;author=C.%20M.%20Brensinger&amp;volume=12&amp;issue=1&amp;publication_year=September%202022&amp;pages=15569&amp;pmid=36114250&amp;doi=10.1038/s41598-022-19551-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0022">
<span class="label">22.</span><cite>
Chen C., Hennessy S., Brensinger C. M., et al., “Antidepressant Drug‐Drug‐Drug Interactions Associated With Unintentional Traumatic Injury: Screening for Signals in Real‐World Data,” Clinical and Translational Science
16, no. 2 (February 2023): 326–337, 10.1111/cts.13452.
</cite> [<a href="https://doi.org/10.1111/cts.13452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9926061/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36415144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20and%20Translational%20Science&amp;title=Antidepressant%20Drug%E2%80%90Drug%E2%80%90Drug%20Interactions%20Associated%20With%20Unintentional%20Traumatic%20Injury:%20Screening%20for%20Signals%20in%20Real%E2%80%90World%20Data&amp;author=C.%20Chen&amp;author=S.%20Hennessy&amp;author=C.%20M.%20Brensinger&amp;volume=16&amp;issue=2&amp;publication_year=February%202023&amp;pages=326-337&amp;pmid=36415144&amp;doi=10.1111/cts.13452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0023">
<span class="label">23.</span><cite>
Chen C., Hennessy S., Brensinger C. M., et al., “Skeletal Muscle Relaxant Drug‐Drug‐Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three‐Way Drug Interaction Signals,” British Journal of Clinical Pharmacology
88, no. 11 (November 2022): 4773–4783, 10.1111/bcp.15395.
</cite> [<a href="https://doi.org/10.1111/bcp.15395" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9560998/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35562168/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=Skeletal%20Muscle%20Relaxant%20Drug%E2%80%90Drug%E2%80%90Drug%20Interactions%20and%20Unintentional%20Traumatic%20Injury:%20Screening%20to%20Detect%20Three%E2%80%90Way%20Drug%20Interaction%20Signals&amp;author=C.%20Chen&amp;author=S.%20Hennessy&amp;author=C.%20M.%20Brensinger&amp;volume=88&amp;issue=11&amp;publication_year=November%202022&amp;pages=4773-4783&amp;pmid=35562168&amp;doi=10.1111/bcp.15395&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0024">
<span class="label">24.</span><cite>
Cohen J. S., “Ways to Minimize Adverse Drug Reactions. Individualized Doses and Common Sense Are Key,” Postgraduate Medicine
106, no. 3 (September 1999): 163–168, 10.3810/pgm.1999.09.688.
</cite> [<a href="https://doi.org/10.3810/pgm.1999.09.688" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10494273/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Postgraduate%20Medicine&amp;title=Ways%20to%20Minimize%20Adverse%20Drug%20Reactions.%20Individualized%20Doses%20and%20Common%20Sense%20Are%20Key&amp;author=J.%20S.%20Cohen&amp;volume=106&amp;issue=3&amp;publication_year=September%201999&amp;pages=163-168&amp;pmid=10494273&amp;doi=10.3810/pgm.1999.09.688&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0025">
<span class="label">25.</span><cite>
Aronson J. K. and Ferner R. E., “The Law of Mass Action and the Pharmacological Concentration‐Effect Curve: Resolving the Paradox of Apparently Non‐Dose‐Related Adverse Drug Reactions,” British Journal of Clinical Pharmacology
81, no. 1 (January 2016): 56–61, 10.1111/bcp.12706.
</cite> [<a href="https://doi.org/10.1111/bcp.12706" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4693576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26119837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=The%20Law%20of%20Mass%20Action%20and%20the%20Pharmacological%20Concentration%E2%80%90Effect%20Curve:%20Resolving%20the%20Paradox%20of%20Apparently%20Non%E2%80%90Dose%E2%80%90Related%20Adverse%20Drug%20Reactions&amp;author=J.%20K.%20Aronson&amp;author=R.%20E.%20Ferner&amp;volume=81&amp;issue=1&amp;publication_year=January%202016&amp;pages=56-61&amp;pmid=26119837&amp;doi=10.1111/bcp.12706&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0026">
<span class="label">26.</span><cite>
Simonsen K. and Sundstedt C. D., “Dose‐Response Relationship and Incidence of Adverse Drug Reactions With Isradipine in Patients With Essential Hypertension,” American Journal of Medicine
86, no. 4A (April 1989): 91–93, 10.1016/0002-9343(89)90199-x.</cite> [<a href="https://doi.org/10.1016/0002-9343(89)90199-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2523663/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Medicine&amp;title=Dose%E2%80%90Response%20Relationship%20and%20Incidence%20of%20Adverse%20Drug%20Reactions%20With%20Isradipine%20in%20Patients%20With%20Essential%20Hypertension&amp;author=K.%20Simonsen&amp;author=C.%20D.%20Sundstedt&amp;volume=86&amp;issue=4A&amp;publication_year=April%201989&amp;pages=91-93&amp;pmid=2523663&amp;doi=10.1016/0002-9343(89)90199-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0027">
<span class="label">27.</span><cite>
Shehab N., Lovegrove M. C., Geller A. I., Rose K. O., Weidle N. J., and Budnitz D. S., “US Emergency Department Visits for Outpatient Adverse Drug Events, 2013‐2014,” Journal of the American Medical Association
316, no. 20 (November 2016): 2115–2125, 10.1001/jama.2016.16201.
</cite> [<a href="https://doi.org/10.1001/jama.2016.16201" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6490178/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27893129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Medical%20Association&amp;title=US%20Emergency%20Department%20Visits%20for%20Outpatient%20Adverse%20Drug%20Events,%202013%E2%80%902014&amp;author=N.%20Shehab&amp;author=M.%20C.%20Lovegrove&amp;author=A.%20I.%20Geller&amp;author=K.%20O.%20Rose&amp;author=N.%20J.%20Weidle&amp;volume=316&amp;issue=20&amp;publication_year=November%202016&amp;pages=2115-2125&amp;pmid=27893129&amp;doi=10.1001/jama.2016.16201&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0028">
<span class="label">28.</span><cite>
Perazella M. A. and Rosner M. H., “Drug‐Induced Acute Kidney Injury,” Clinical Journal of the American Society of Nephrology
17, no. 8 (August 2022): 1220–1233, 10.2215/CJN.11290821.
</cite> [<a href="https://doi.org/10.2215/CJN.11290821" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9435983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35273009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Journal%20of%20the%20American%20Society%20of%20Nephrology&amp;title=Drug%E2%80%90Induced%20Acute%20Kidney%20Injury&amp;author=M.%20A.%20Perazella&amp;author=M.%20H.%20Rosner&amp;volume=17&amp;issue=8&amp;publication_year=August%202022&amp;pages=1220-1233&amp;pmid=35273009&amp;doi=10.2215/CJN.11290821&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0029">
<span class="label">29.</span><cite>
US Department of Health and Human Services
, “National Action Plan for Adverse Drug Event Prevention,” (2025), <a href="https://odphp.health.gov/sites/default/files/2019-09/ADE-Action-Plan-508c.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://odphp.health.gov/sites/default/files/2019‐09/ADE‐Action‐Plan‐508c.pdf</a>.</cite>
</li>
<li id="pds70199-bib-0030">
<span class="label">30.</span><cite>
Eldridge N., Wang Y., Metersky M., et al., “Trends in Adverse Event Rates in Hospitalized Patients, 2010‐2019,” JAMA
328, no. 2 (2022): 173–183, 10.1001/jama.2022.9600.
</cite> [<a href="https://doi.org/10.1001/jama.2022.9600" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9277501/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35819424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Trends%20in%20Adverse%20Event%20Rates%20in%20Hospitalized%20Patients,%202010%E2%80%902019&amp;author=N.%20Eldridge&amp;author=Y.%20Wang&amp;author=M.%20Metersky&amp;volume=328&amp;issue=2&amp;publication_year=2022&amp;pages=173-183&amp;pmid=35819424&amp;doi=10.1001/jama.2022.9600&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0031">
<span class="label">31.</span><cite>
Calvo Barbado D. M., Saiz Fernandez L. C., Leache Alegria L., Celaya Lecea M. C., and Gutierrez‐Valencia M., “Acute Kidney Injury Associated With “Triple Whammy” Combination: A Protocol for a Systematic Review,” F1000Research
11 (2022): 496, 10.12688/f1000research.109987.2.
</cite> [<a href="https://doi.org/10.12688/f1000research.109987.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9889944/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36761833/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=F1000Research&amp;title=Acute%20Kidney%20Injury%20Associated%20With%20%E2%80%9CTriple%20Whammy%E2%80%9D%20Combination:%20A%20Protocol%20for%20a%20Systematic%20Review&amp;author=D.%20M.%20Calvo%20Barbado&amp;author=L.%20C.%20Saiz%20Fernandez&amp;author=L.%20Leache%20Alegria&amp;author=M.%20C.%20Celaya%20Lecea&amp;author=M.%20Gutierrez%E2%80%90Valencia&amp;volume=11&amp;publication_year=2022&amp;pages=496&amp;pmid=36761833&amp;doi=10.12688/f1000research.109987.2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0032">
<span class="label">32.</span><cite>
Ferner R. and Aronson J., “Susceptibility to Adverse Drug Reactions,” British Journal of Clinical Pharmacology
85, no. 10 (October 2019): 2205–2212, 10.1111/bcp.14015.
</cite> [<a href="https://doi.org/10.1111/bcp.14015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6783620/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31169324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=Susceptibility%20to%20Adverse%20Drug%20Reactions&amp;author=R.%20Ferner&amp;author=J.%20Aronson&amp;volume=85&amp;issue=10&amp;publication_year=October%202019&amp;pages=2205-2212&amp;pmid=31169324&amp;doi=10.1111/bcp.14015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0033">
<span class="label">33.</span><cite>
Kotlinska‐Lemieszek A., Klepstad P., and Haugen D. F., “Clinically Significant Drug‐Drug Interactions Involving Opioid Analgesics Used for Pain Treatment in Patients With Cancer: Update of a Systematic Review,” Expert Opinion on Drug Metabolism &amp; Toxicology
21 (2025): 703, 10.1080/17425255.2025.2491743.
</cite> [<a href="https://doi.org/10.1080/17425255.2025.2491743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40227246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opinion%20on%20Drug%20Metabolism%20&amp;%20Toxicology&amp;title=Clinically%20Significant%20Drug%E2%80%90Drug%20Interactions%20Involving%20Opioid%20Analgesics%20Used%20for%20Pain%20Treatment%20in%20Patients%20With%20Cancer:%20Update%20of%20a%20Systematic%20Review&amp;author=A.%20Kotlinska%E2%80%90Lemieszek&amp;author=P.%20Klepstad&amp;author=D.%20F.%20Haugen&amp;volume=21&amp;publication_year=2025&amp;pages=703&amp;pmid=40227246&amp;doi=10.1080/17425255.2025.2491743&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0034">
<span class="label">34.</span><cite>
Li A., Li M. K., Crowther M., and Vazquez S. R., “Drug‐Drug Interactions With Direct Oral Anticoagulants Associated With Adverse Events in the Real World: A Systematic Review,” Thrombosis Research
194 (2020): 240–245, 10.1016/j.thromres.2020.08.016.
</cite> [<a href="https://doi.org/10.1016/j.thromres.2020.08.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7417902/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33213849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Thrombosis%20Research&amp;title=Drug%E2%80%90Drug%20Interactions%20With%20Direct%20Oral%20Anticoagulants%20Associated%20With%20Adverse%20Events%20in%20the%20Real%20World:%20A%20Systematic%20Review&amp;author=A.%20Li&amp;author=M.%20K.%20Li&amp;author=M.%20Crowther&amp;author=S.%20R.%20Vazquez&amp;volume=194&amp;publication_year=2020&amp;pages=240-245&amp;pmid=33213849&amp;doi=10.1016/j.thromres.2020.08.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0035">
<span class="label">35.</span><cite>
Patton K. and Borshoff D. C., “Adverse Drug Reactions,” Anaesthesia
73, no. Suppl 1 (January 2018): 76–84, 10.1111/anae.14143.
</cite> [<a href="https://doi.org/10.1111/anae.14143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29313907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anaesthesia&amp;title=Adverse%20Drug%20Reactions&amp;author=K.%20Patton&amp;author=D.%20C.%20Borshoff&amp;volume=73&amp;issue=Suppl%201&amp;publication_year=January%202018&amp;pages=76-84&amp;pmid=29313907&amp;doi=10.1111/anae.14143&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0036">
<span class="label">36.</span><cite>
Schneeweiss S., Rassen J. A., Brown J. S., et al., “Graphical Depiction of Longitudinal Study Designs in Health Care Databases,” Annals of Internal Medicine
170, no. 6 (March 2019): 398–406, 10.7326/M18-3079.
</cite> [<a href="https://doi.org/10.7326/M18-3079" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30856654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Internal%20Medicine&amp;title=Graphical%20Depiction%20of%20Longitudinal%20Study%20Designs%20in%20Health%20Care%20Databases&amp;author=S.%20Schneeweiss&amp;author=J.%20A.%20Rassen&amp;author=J.%20S.%20Brown&amp;volume=170&amp;issue=6&amp;publication_year=March%202019&amp;pages=398-406&amp;pmid=30856654&amp;doi=10.7326/M18-3079&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0037">
<span class="label">37.</span><cite>
Patel U., Hardy N., Smith D., et al., “Validation of Acute Kidney Injury Cases in the Mini‐Sentinel Distributed Database,”
<a href="https://www.sentinelinitiative.org/sites/default/files/Drugs/Assessments/Mini-Sentinel_Validation-of-Acute-Kidney-Injury-Cases.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sentinelinitiative.org/sites/default/files/Drugs/Assessments/Mini‐Sentinel_Validation‐of‐Acute‐Kidney‐Injury‐Cases.pdf</a>.</cite>
</li>
<li id="pds70199-bib-0038">
<span class="label">38.</span><cite>
Saunders‐Hastings P., Heong S. W., Srichaikul J., et al., “Acute Myocardial Infarction: Development and Application of an ICD‐10‐CM‐Based Algorithm to a Large U.S. Healthcare Claims‐Based Database,” PLoS One
16, no. 7 (2021): e0253580, 10.1371/journal.pone.0253580.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0253580" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8248590/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34197488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Acute%20Myocardial%20Infarction:%20Development%20and%20Application%20of%20an%20ICD%E2%80%9010%E2%80%90CM%E2%80%90Based%20Algorithm%20to%20a%20Large%20U.S.%20Healthcare%20Claims%E2%80%90Based%20Database&amp;author=P.%20Saunders%E2%80%90Hastings&amp;author=S.%20W.%20Heong&amp;author=J.%20Srichaikul&amp;volume=16&amp;issue=7&amp;publication_year=2021&amp;pages=e0253580&amp;pmid=34197488&amp;doi=10.1371/journal.pone.0253580&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0039">
<span class="label">39.</span><cite>
U.S. Food and Drug Administration (FDA)
, “Gastrointestinal Bleed Algorithm Defined in Stroke, Gastrointestinal Bleeding, and Intracranial Hemorrhage Following Apixaban or Warfarin Use in Patients With Non‐Valvular Atrial Fibrillation: A Propensity Score Matched Analysis,”
<a href="https://www.sentinelinitiative.org/sites/default/files/surveillance-tools/validations-literature/GI_Bleed_apixaban_final_codelist.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.sentinelinitiative.org/sites/default/files/surveillance‐tools/validations‐literature/GI_Bleed_apixaban_final_codelist.pdf</a>.</cite>
</li>
<li id="pds70199-bib-0040">
<span class="label">40.</span><cite>
Digmann R., Thomas A., Peppercorn S., et al., “Use of Medicare Administrative Claims to Identify a Population at High Risk for Adverse Drug Events and Hospital Use for Quality Improvement,” Journal of Managed Care &amp; Specialty Pharmacy
25, no. 3 (March 2019): 402–410, 10.18553/jmcp.2019.25.3.402.
</cite> [<a href="https://doi.org/10.18553/jmcp.2019.25.3.402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10397735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30816813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Managed%20Care%20&amp;%20Specialty%20Pharmacy&amp;title=Use%20of%20Medicare%20Administrative%20Claims%20to%20Identify%20a%20Population%20at%20High%20Risk%20for%20Adverse%20Drug%20Events%20and%20Hospital%20Use%20for%20Quality%20Improvement&amp;author=R.%20Digmann&amp;author=A.%20Thomas&amp;author=S.%20Peppercorn&amp;volume=25&amp;issue=3&amp;publication_year=March%202019&amp;pages=402-410&amp;pmid=30816813&amp;doi=10.18553/jmcp.2019.25.3.402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0041">
<span class="label">41.</span><cite>
Karter A. J., Warton E. M., Moffet H. H., et al., “Revalidation of the Hypoglycemia Risk Stratification Tool Using ICD‐10 Codes,” Diabetes Care
42, no. 4 (April 2019): e58–e59, 10.2337/dc18-2154.
</cite> [<a href="https://doi.org/10.2337/dc18-2154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6429629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30765427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Diabetes%20Care&amp;title=Revalidation%20of%20the%20Hypoglycemia%20Risk%20Stratification%20Tool%20Using%20ICD%E2%80%9010%20Codes&amp;author=A.%20J.%20Karter&amp;author=E.%20M.%20Warton&amp;author=H.%20H.%20Moffet&amp;volume=42&amp;issue=4&amp;publication_year=April%202019&amp;pages=e58-e59&amp;pmid=30765427&amp;doi=10.2337/dc18-2154&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0042">
<span class="label">42.</span><cite>
Gasparini A., “R Package ‘comorbidity’,”
<a href="https://cran.r-project.org/web/packages/comorbidity/comorbidity.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://cran.r‐project.org/web/packages/comorbidity/comorbidity.pdf</a>.</cite>
</li>
<li id="pds70199-bib-0043">
<span class="label">43.</span><cite>
Finlay S., Bray B., Lewington A. J., et al., “Identification of Risk Factors Associated With Acute Kidney Injury in Patients Admitted to Acute Medical Units,” Clinical Medicine (London, England)
13, no. 3 (June 2013): 233–238, 10.7861/clinmedicine.13-3-233.
</cite> [<a href="https://doi.org/10.7861/clinmedicine.13-3-233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5922664/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23760694/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Medicine%20(London,%20England)&amp;title=Identification%20of%20Risk%20Factors%20Associated%20With%20Acute%20Kidney%20Injury%20in%20Patients%20Admitted%20to%20Acute%20Medical%20Units&amp;author=S.%20Finlay&amp;author=B.%20Bray&amp;author=A.%20J.%20Lewington&amp;volume=13&amp;issue=3&amp;publication_year=June%202013&amp;pages=233-238&amp;pmid=23760694&amp;doi=10.7861/clinmedicine.13-3-233&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0044">
<span class="label">44.</span><cite>
Khwaja A., “KDIGO Clinical Practice Guidelines for Acute Kidney Injury,” Nephron Clinical Practice
120, no. 4 (2012): c179–c184, 10.1159/000339789.
</cite> [<a href="https://doi.org/10.1159/000339789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22890468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nephron%20Clinical%20Practice&amp;title=KDIGO%20Clinical%20Practice%20Guidelines%20for%20Acute%20Kidney%20Injury&amp;author=A.%20Khwaja&amp;volume=120&amp;issue=4&amp;publication_year=2012&amp;pages=c179-c184&amp;pmid=22890468&amp;doi=10.1159/000339789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0045">
<span class="label">45.</span><cite>
Rathore V., Singh N., and Mahat R., “Risk Factors for Acute Myocardial Infarction: A Review,” EJMI
2, no. 1 (2018): 1–7.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=EJMI&amp;title=Risk%20Factors%20for%20Acute%20Myocardial%20Infarction:%20A%20Review&amp;author=V.%20Rathore&amp;author=N.%20Singh&amp;author=R.%20Mahat&amp;volume=2&amp;issue=1&amp;publication_year=2018&amp;pages=1-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0046">
<span class="label">46.</span><cite>
Tielleman T., Bujanda D., and Cryer B., “Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding,” Gastrointestinal Endoscopy Clinics of North America
25, no. 3 (July 2015): 415–428, 10.1016/j.giec.2015.02.010.
</cite> [<a href="https://doi.org/10.1016/j.giec.2015.02.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26142028/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gastrointestinal%20Endoscopy%20Clinics%20of%20North%20America&amp;title=Epidemiology%20and%20Risk%20Factors%20for%20Upper%20Gastrointestinal%20Bleeding&amp;author=T.%20Tielleman&amp;author=D.%20Bujanda&amp;author=B.%20Cryer&amp;volume=25&amp;issue=3&amp;publication_year=July%202015&amp;pages=415-428&amp;pmid=26142028&amp;doi=10.1016/j.giec.2015.02.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0047">
<span class="label">47.</span><cite>
Lenti M. V., Pasina L., Cococcia S., et al., “Mortality Rate and Risk Factors for Gastrointestinal Bleeding in Elderly Patients,” European Journal of Internal Medicine
61 (March 2019): 54–61, 10.1016/j.ejim.2018.11.003.
</cite> [<a href="https://doi.org/10.1016/j.ejim.2018.11.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30522789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Internal%20Medicine&amp;title=Mortality%20Rate%20and%20Risk%20Factors%20for%20Gastrointestinal%20Bleeding%20in%20Elderly%20Patients&amp;author=M.%20V.%20Lenti&amp;author=L.%20Pasina&amp;author=S.%20Cococcia&amp;volume=61&amp;publication_year=March%202019&amp;pages=54-61&amp;pmid=30522789&amp;doi=10.1016/j.ejim.2018.11.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0048">
<span class="label">48.</span><cite>
Vonbach P., Reich R., Moll F., Krahenbuhl S., Ballmer P. E., and Meier C. R., “Risk Factors for Gastrointestinal Bleeding: A Hospital‐Based Case‐Control Study,” Swiss Medical Weekly
137, no. 49–50 (December 2007): 705–710, 10.4414/smw.2007.11912.
</cite> [<a href="https://doi.org/10.4414/smw.2007.11912" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18197486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Swiss%20Medical%20Weekly&amp;title=Risk%20Factors%20for%20Gastrointestinal%20Bleeding:%20A%20Hospital%E2%80%90Based%20Case%E2%80%90Control%20Study&amp;author=P.%20Vonbach&amp;author=R.%20Reich&amp;author=F.%20Moll&amp;author=S.%20Krahenbuhl&amp;author=P.%20E.%20Ballmer&amp;volume=137&amp;issue=49%E2%80%9350&amp;publication_year=December%202007&amp;pages=705-710&amp;pmid=18197486&amp;doi=10.4414/smw.2007.11912&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0049">
<span class="label">49.</span><cite>
Strate L. L., Ayanian J. Z., Kotler G., and Syngal S., “Risk Factors for Mortality in Lower Intestinal Bleeding,” Clinical Gastroenterology and Hepatology
6, no. 9 (September 2008): 1004–1010, 10.1016/j.cgh.2008.03.021.
</cite> [<a href="https://doi.org/10.1016/j.cgh.2008.03.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2643270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18558513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Gastroenterology%20and%20Hepatology&amp;title=Risk%20Factors%20for%20Mortality%20in%20Lower%20Intestinal%20Bleeding&amp;author=L.%20L.%20Strate&amp;author=J.%20Z.%20Ayanian&amp;author=G.%20Kotler&amp;author=S.%20Syngal&amp;volume=6&amp;issue=9&amp;publication_year=September%202008&amp;pages=1004-1010&amp;pmid=18558513&amp;doi=10.1016/j.cgh.2008.03.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0050">
<span class="label">50.</span><cite>
Webster L. R., “Risk Factors for Opioid‐Use Disorder and Overdose,” Anesthesia and Analgesia
125, no. 5 (November 2017): 1741–1748, 10.1213/ANE.0000000000002496.
</cite> [<a href="https://doi.org/10.1213/ANE.0000000000002496" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29049118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anesthesia%20and%20Analgesia&amp;title=Risk%20Factors%20for%20Opioid%E2%80%90Use%20Disorder%20and%20Overdose&amp;author=L.%20R.%20Webster&amp;volume=125&amp;issue=5&amp;publication_year=November%202017&amp;pages=1741-1748&amp;pmid=29049118&amp;doi=10.1213/ANE.0000000000002496&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0051">
<span class="label">51.</span><cite>
Silbert R., Salcido‐Montenegro A., Rodriguez‐Gutierrez R., Katabi A., and McCoy R. G., “Hypoglycemia Among Patients With Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies,” Current Diabetes Reports
18, no. 8 (June 2018): 53, 10.1007/s11892-018-1018-0.
</cite> [<a href="https://doi.org/10.1007/s11892-018-1018-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6117835/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29931579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Diabetes%20Reports&amp;title=Hypoglycemia%20Among%20Patients%20With%20Type%202%20Diabetes:%20Epidemiology,%20Risk%20Factors,%20and%20Prevention%20Strategies&amp;author=R.%20Silbert&amp;author=A.%20Salcido%E2%80%90Montenegro&amp;author=R.%20Rodriguez%E2%80%90Gutierrez&amp;author=A.%20Katabi&amp;author=R.%20G.%20McCoy&amp;volume=18&amp;issue=8&amp;publication_year=June%202018&amp;pages=53&amp;pmid=29931579&amp;doi=10.1007/s11892-018-1018-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0052">
<span class="label">52.</span><cite>
Nelson S. J., Zeng K., Kilbourne J., Powell T., and Moore R., “Normalized Names for Clinical Drugs: RxNorm at 6 Years,” Journal of the American Medical Informatics Association
18, no. 4 (2011): 441–448, 10.1136/amiajnl-2011-000116.
</cite> [<a href="https://doi.org/10.1136/amiajnl-2011-000116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3128404/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21515544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Medical%20Informatics%20Association&amp;title=Normalized%20Names%20for%20Clinical%20Drugs:%20RxNorm%20at%206%E2%80%89Years&amp;author=S.%20J.%20Nelson&amp;author=K.%20Zeng&amp;author=J.%20Kilbourne&amp;author=T.%20Powell&amp;author=R.%20Moore&amp;volume=18&amp;issue=4&amp;publication_year=2011&amp;pages=441-448&amp;pmid=21515544&amp;doi=10.1136/amiajnl-2011-000116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0053">
<span class="label">53.</span><cite>
Side Effect
, “Side Effect Resource (SIDER 4.1),”
<a href="http://sideeffects.embl.de/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://sideeffects.embl.de/</a>.</cite>
</li>
<li id="pds70199-bib-0054">
<span class="label">54.</span><cite>
Demner‐Fushman D., Shooshan S. E., Rodriguez L., et al., “A Dataset of 200 Structured Product Labels Annotated for Adverse Drug Reactions,” Scientific Data
5 (January 2018): 180001, 10.1038/sdata.2018.1.
</cite> [<a href="https://doi.org/10.1038/sdata.2018.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5789866/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29381145/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Data&amp;title=A%20Dataset%20of%20200%20Structured%20Product%20Labels%20Annotated%20for%20Adverse%20Drug%20Reactions&amp;author=D.%20Demner%E2%80%90Fushman&amp;author=S.%20E.%20Shooshan&amp;author=L.%20Rodriguez&amp;volume=5&amp;publication_year=January%202018&amp;pages=180001&amp;pmid=29381145&amp;doi=10.1038/sdata.2018.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0055">
<span class="label">55.</span><cite>
Benjamini Y. and Hochberg Y., “Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing,” Journal of the Royal Statistical Society: Series B: Methodological
75, no. 7 (1995): 289–300, 10.1111/j.2517-6161.1995.tb02031.x.</cite> [<a href="https://doi.org/10.1111/j.2517-6161.1995.tb02031.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Royal%20Statistical%20Society:%20Series%20B:%20Methodological&amp;title=Controlling%20the%20False%20Discovery%20Rate:%20A%20Practical%20and%20Powerful%20Approach%20to%20Multiple%20Testing&amp;author=Y.%20Benjamini&amp;author=Y.%20Hochberg&amp;volume=75&amp;issue=7&amp;publication_year=1995&amp;pages=289-300&amp;doi=10.1111/j.2517-6161.1995.tb02031.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0056">
<span class="label">56.</span><cite>
Chimirri S., Aiello R., Mazzitello C., et al., “Vertigo/Dizziness as a Drugs' Adverse Reaction,” Journal of Pharmacy and Pharmacology
4, no. Suppl 1 (December 2013): S104–S109, 10.4103/0976-500X.120969.</cite> [<a href="https://doi.org/10.4103/0976-500X.120969" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3853661/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24347974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacy%20and%20Pharmacology&amp;title=Vertigo/Dizziness%20as%20a%20Drugs'%20Adverse%20Reaction&amp;author=S.%20Chimirri&amp;author=R.%20Aiello&amp;author=C.%20Mazzitello&amp;volume=4&amp;issue=Suppl%201&amp;publication_year=December%202013&amp;pages=S104-S109&amp;pmid=24347974&amp;doi=10.4103/0976-500X.120969&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0057">
<span class="label">57.</span><cite>
Rodrigues‐Amorim D., Olivares J. M., Spuch C., and Rivera‐Baltanas T., “A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine,” Frontiers in Psychiatry
11 (2020): 554899, 10.3389/fpsyt.2020.554899.
</cite> [<a href="https://doi.org/10.3389/fpsyt.2020.554899" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7644852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33192668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Psychiatry&amp;title=A%20Systematic%20Review%20of%20Efficacy,%20Safety,%20and%20Tolerability%20of%20Duloxetine&amp;author=D.%20Rodrigues%E2%80%90Amorim&amp;author=J.%20M.%20Olivares&amp;author=C.%20Spuch&amp;author=T.%20Rivera%E2%80%90Baltanas&amp;volume=11&amp;publication_year=2020&amp;pages=554899&amp;pmid=33192668&amp;doi=10.3389/fpsyt.2020.554899&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0058">
<span class="label">58.</span><cite>
Herman L., Weber P., and Bashir K., “Hydrochlorothiazide,”
<a href="https://www.ncbi.nlm.nih.gov/sites/books/NBK430766/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/sites/books/NBK430766/</a>.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/28613517/" class="usa-link">PubMed</a>]</li>
<li id="pds70199-bib-0059">
<span class="label">59.</span><cite>
Pierson‐Marchandise M., Gras V., Moragny J., et al., “The Drugs That Mostly Frequently Induce Acute Kidney Injury: A Case–Noncase Study of a Pharmacovigilance Database,” British Journal of Clinical Pharmacology
83, no. 6 (June 2017): 1341–1349, 10.1111/bcp.13216.
</cite> [<a href="https://doi.org/10.1111/bcp.13216" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5427222/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28002877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=British%20Journal%20of%20Clinical%20Pharmacology&amp;title=The%20Drugs%20That%20Mostly%20Frequently%20Induce%20Acute%20Kidney%20Injury:%20A%20Case%E2%80%93Noncase%20Study%20of%20a%20Pharmacovigilance%20Database&amp;author=M.%20Pierson%E2%80%90Marchandise&amp;author=V.%20Gras&amp;author=J.%20Moragny&amp;volume=83&amp;issue=6&amp;publication_year=June%202017&amp;pages=1341-1349&amp;pmid=28002877&amp;doi=10.1111/bcp.13216&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0060">
<span class="label">60.</span><cite>
Mallappallil M., Sabu J., Friedman E. A., and Salifu M., “What Do we Know About Opioids and the Kidney?,” International Journal of Molecular Sciences
18, no. 1 (January 2017): 223, 10.3390/ijms18010223.
</cite> [<a href="https://doi.org/10.3390/ijms18010223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5297852/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28117754/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=What%20Do%20we%20Know%20About%20Opioids%20and%20the%20Kidney?&amp;author=M.%20Mallappallil&amp;author=J.%20Sabu&amp;author=E.%20A.%20Friedman&amp;author=M.%20Salifu&amp;volume=18&amp;issue=1&amp;publication_year=January%202017&amp;pages=223&amp;pmid=28117754&amp;doi=10.3390/ijms18010223&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0061">
<span class="label">61.</span><cite>
Torregrosa‐de Juan E., Olague‐Diaz P., Royo‐Maicas P., Fernandez‐Najera E., and Garcia‐Maset R., “Acute Renal Failure due to Gabapentin. A Case Report and Literature,” Nefrología
32, no. 1 (2012): 130–131, 10.3265/Nefrologia.pre2011.Nov.11087.
</cite> [<a href="https://doi.org/10.3265/Nefrologia.pre2011.Nov.11087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22294020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nefrolog%C3%ADa&amp;title=Acute%20Renal%20Failure%20due%20to%20Gabapentin.%20A%20Case%20Report%20and%20Literature&amp;author=E.%20Torregrosa%E2%80%90de%20Juan&amp;author=P.%20Olague%E2%80%90Diaz&amp;author=P.%20Royo%E2%80%90Maicas&amp;author=E.%20Fernandez%E2%80%90Najera&amp;author=R.%20Garcia%E2%80%90Maset&amp;volume=32&amp;issue=1&amp;publication_year=2012&amp;pages=130-131&amp;pmid=22294020&amp;doi=10.3265/Nefrologia.pre2011.Nov.11087&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0062">
<span class="label">62.</span><cite>
Khanimov I., Segal G., Wainstein J., Boaz M., Shimonov M., and Leibovitz E., “High‐Intensity Statins Are Associated With Increased Incidence of Hypoglycemia During Hospitalization of Individuals Not Critically Ill,” American Journal of Medicine
132, no. 11 (November 2019): 1305–1310, 10.1016/j.amjmed.2019.04.050.
</cite> [<a href="https://doi.org/10.1016/j.amjmed.2019.04.050" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31233703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Medicine&amp;title=High%E2%80%90Intensity%20Statins%20Are%20Associated%20With%20Increased%20Incidence%20of%20Hypoglycemia%20During%20Hospitalization%20of%20Individuals%20Not%20Critically%20Ill&amp;author=I.%20Khanimov&amp;author=G.%20Segal&amp;author=J.%20Wainstein&amp;author=M.%20Boaz&amp;author=M.%20Shimonov&amp;volume=132&amp;issue=11&amp;publication_year=November%202019&amp;pages=1305-1310&amp;pmid=31233703&amp;doi=10.1016/j.amjmed.2019.04.050&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0063">
<span class="label">63.</span><cite>
Caamano F., Pedone C., Zuccala G., and Carbonin P., “Socio‐Demographic Factors Related to the Prevalence of Adverse Drug Reaction at Hospital Admission in an Elderly Population,” Archives of Gerontology and Geriatrics
40, no. 1 (2005): 45–52, 10.1016/j.archger.2004.05.005.
</cite> [<a href="https://doi.org/10.1016/j.archger.2004.05.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15531022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Archives%20of%20Gerontology%20and%20Geriatrics&amp;title=Socio%E2%80%90Demographic%20Factors%20Related%20to%20the%20Prevalence%20of%20Adverse%20Drug%20Reaction%20at%20Hospital%20Admission%20in%20an%20Elderly%20Population&amp;author=F.%20Caamano&amp;author=C.%20Pedone&amp;author=G.%20Zuccala&amp;author=P.%20Carbonin&amp;volume=40&amp;issue=1&amp;publication_year=2005&amp;pages=45-52&amp;pmid=15531022&amp;doi=10.1016/j.archger.2004.05.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0064">
<span class="label">64.</span><cite>
CDC: Centers for Disease Control and Prevention
, “FastStats: Medication Safety Data,” (2025), <a href="https://www.cdc.gov/medication-safety/data-research/facts-stats/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/medication‐safety/data‐research/facts‐stats/index.html</a>.</cite>
</li>
<li id="pds70199-bib-0065">
<span class="label">65.</span><cite>
Bates B. A., Akhabue E., Nahass M. M., et al., “Validity of International Classification of Diseases (ICD)‐10 Diagnosis Codes for Identification of Acute Heart Failure Hospitalization and Heart Failure With Reduced Versus Preserved Ejection Fraction in a National Medicare Sample,” Circulation. Cardiovascular Quality and Outcomes
16, no. 2 (February 2023): e009078, 10.1161/CIRCOUTCOMES.122.009078.
</cite> [<a href="https://doi.org/10.1161/CIRCOUTCOMES.122.009078" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36688301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation.%20Cardiovascular%20Quality%20and%20Outcomes&amp;title=Validity%20of%20International%20Classification%20of%20Diseases%20(ICD)%E2%80%9010%20Diagnosis%20Codes%20for%20Identification%20of%20Acute%20Heart%20Failure%20Hospitalization%20and%20Heart%20Failure%20With%20Reduced%20Versus%20Preserved%20Ejection%20Fraction%20in%20a%20National%20Medicare%20Sample&amp;author=B.%20A.%20Bates&amp;author=E.%20Akhabue&amp;author=M.%20M.%20Nahass&amp;volume=16&amp;issue=2&amp;publication_year=February%202023&amp;pages=e009078&amp;pmid=36688301&amp;doi=10.1161/CIRCOUTCOMES.122.009078&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0066">
<span class="label">66.</span><cite>
Li Q., Glynn R. J., Dreyer N. A., Liu J., Mogun H., and Setoguchi S., “Validity of Claims‐Based Definitions of Left Ventricular Systolic Dysfunction in Medicare Patients,” Pharmacoepidemiology and Drug Safety
20, no. 7 (July 2011): 700–708, 10.1002/pds.2146.
</cite> [<a href="https://doi.org/10.1002/pds.2146" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21608070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoepidemiology%20and%20Drug%20Safety&amp;title=Validity%20of%20Claims%E2%80%90Based%20Definitions%20of%20Left%20Ventricular%20Systolic%20Dysfunction%20in%20Medicare%20Patients&amp;author=Q.%20Li&amp;author=R.%20J.%20Glynn&amp;author=N.%20A.%20Dreyer&amp;author=J.%20Liu&amp;author=H.%20Mogun&amp;volume=20&amp;issue=7&amp;publication_year=July%202011&amp;pages=700-708&amp;pmid=21608070&amp;doi=10.1002/pds.2146&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0067">
<span class="label">67.</span><cite>
Shi Y., Sun A., Yang Y., et al., “A Theoretical Model for Detecting Drug Interaction With Awareness of Timing of Exposure,” Scientific Reports
15, no. 1 (April 2025): 13693, 10.1038/s41598-025-98528-5.
</cite> [<a href="https://doi.org/10.1038/s41598-025-98528-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12012107/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40258952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=A%20Theoretical%20Model%20for%20Detecting%20Drug%20Interaction%20With%20Awareness%20of%20Timing%20of%20Exposure&amp;author=Y.%20Shi&amp;author=A.%20Sun&amp;author=Y.%20Yang&amp;volume=15&amp;issue=1&amp;publication_year=April%202025&amp;pages=13693&amp;pmid=40258952&amp;doi=10.1038/s41598-025-98528-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0068">
<span class="label">68.</span><cite>
Makki N., Hajj G., and Schmidt G. A., “Seizure‐Induced Acute Urate Nephropathy: Case Report and Review,” Chest
144, no. 2 (August 2013): 666–669, 10.1378/chest.12-2129.
</cite> [<a href="https://doi.org/10.1378/chest.12-2129" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23918111/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Seizure%E2%80%90Induced%20Acute%20Urate%20Nephropathy:%20Case%20Report%20and%20Review&amp;author=N.%20Makki&amp;author=G.%20Hajj&amp;author=G.%20A.%20Schmidt&amp;volume=144&amp;issue=2&amp;publication_year=August%202013&amp;pages=666-669&amp;pmid=23918111&amp;doi=10.1378/chest.12-2129&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0069">
<span class="label">69.</span><cite>
Rosner M. H. and Perazella M. A., “Acute Kidney Injury in the Patient With Cancer,” Kidney Research and Clinical Practice
38, no. 3 (September 2019): 295–308, 10.23876/j.krcp.19.042.
</cite> [<a href="https://doi.org/10.23876/j.krcp.19.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6727896/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31284363/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Research%20and%20Clinical%20Practice&amp;title=Acute%20Kidney%20Injury%20in%20the%20Patient%20With%20Cancer&amp;author=M.%20H.%20Rosner&amp;author=M.%20A.%20Perazella&amp;volume=38&amp;issue=3&amp;publication_year=September%202019&amp;pages=295-308&amp;pmid=31284363&amp;doi=10.23876/j.krcp.19.042&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pds70199-bib-0070">
<span class="label">70.</span><cite>
Drugs.com
, “Duloxetine Dosage,”
<a href="https://www.drugs.com/dosage/duloxetine.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.drugs.com/dosage/duloxetine.html</a>.</cite>
</li>
<li id="pds70199-bib-0071">
<span class="label">71.</span><cite>
Drgus.com
, “Hydrochlorothiazide Dosage,”
<a href="https://www.drugs.com/dosage/hydrochlorothiazide.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.drugs.com/dosage/hydrochlorothiazide.html</a>.</cite>
</li>
<li id="pds70199-bib-0072">
<span class="label">72.</span><cite>
Drugs.com
, “Hydrocodone Dosage,”
<a href="https://www.drugs.com/dosage/hydrocodone.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.drugs.com/dosage/hydrocodone.html</a>.</cite>
</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12358767/bin/PDS-34-e70199-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">PDS-34-e70199-s001.docx</a><sup> (26.5KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<p>
<strong>Table S1:</strong> drugs in the tested three‐drug combinations.</p>
<p>
<strong>Table S2:</strong> Signals of adverse three‐drug combinations. High level: dose &gt; Cutoff; Low level: 0 &lt; dose ≤ Cutoff; OR: odds ratio compared with no exposure; P: <em>p</em> value for testing a significant risk reduction compared with the highest dose under <em>z</em>‐test; 222: doses of all three drugs at the highest level; 122/212/221: reducing dose of Drug_1/Drug_2/Drug_3 to low level; 112/121/211: reducing doses of Drug_1 and Drug 2/Drug_1 and Drug_3/Drug_2 and Drug_3 to low level; 022/202/220: discontinue of Drug_1/Drug_2/Drug_3; 111: reducing doses of all three drugs to low level.</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12358767/bin/PDS-34-e70199-s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">PDS-34-e70199-s002.xlsx</a><sup> (97.2KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Optum's de‐identified Clinformatics Data Mart Database is not publicly available (accessibility can be obtained from Optum: <a href="http://optum.com" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">optum.com</a>). Summary statistics generated during this study are included in this published article and its <a href="#pds70199-supitem-0001" class="usa-link">Supporting Information</a> files.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Pharmacoepidemiology and Drug Safety are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/pds.70199"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/PDS-34-e70199.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12358767/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12358767/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12358767%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12358767/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12358767/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12358767/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40820442/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12358767/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40820442/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12358767/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12358767/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="lxxVzNki4wLmBae6PhzuegeEimisnB5mSKsgd36qS0eZOHfjfRU2v1c3DuMVHwry">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
